KR20130044178A - Polymerizable chiral compound - Google Patents

Polymerizable chiral compound Download PDF

Info

Publication number
KR20130044178A
KR20130044178A KR1020120116633A KR20120116633A KR20130044178A KR 20130044178 A KR20130044178 A KR 20130044178A KR 1020120116633 A KR1020120116633 A KR 1020120116633A KR 20120116633 A KR20120116633 A KR 20120116633A KR 20130044178 A KR20130044178 A KR 20130044178A
Authority
KR
South Korea
Prior art keywords
oco
coo
group
formula
independently
Prior art date
Application number
KR1020120116633A
Other languages
Korean (ko)
Inventor
마사나오 하야시
마사히로 호리구치
데츠오 구스모토
Original Assignee
디아이씨 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디아이씨 가부시끼가이샤 filed Critical 디아이씨 가부시끼가이샤
Publication of KR20130044178A publication Critical patent/KR20130044178A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G61/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G61/12Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G61/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G61/12Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule
    • C08G61/122Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule derived from five- or six-membered heterocyclic compounds, other than imides
    • C08G61/123Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule derived from five- or six-membered heterocyclic compounds, other than imides derived from five-membered heterocyclic compounds
    • C08G61/125Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule derived from five- or six-membered heterocyclic compounds, other than imides derived from five-membered heterocyclic compounds with a five-membered ring containing one oxygen atom in the ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polarising Elements (AREA)
  • Epoxy Resins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

PURPOSE: A polymerization chiral compound is provided to manufacture an optical anisotropic body which has an excellent optical property due to a strong torsional force. CONSTITUTION: A polymerization group of a polymerization chiral compound is hardened by radical polymerization, radical addition polymerization, cationic polymerization, and anion polymerization. The polymerization chiral compound is indicated as a general formula (I). The polymerization chiral compound obtains high HTP by increasing rigidity of a mesogen region due to direct combination of a ring skeleton and a polymeric group. As solubility of the polymerization chiral compound improves, optical anisotropic body obtains an excellent reflection property for a liquid crystal composition.

Description

중합성 키랄 화합물{POLYMERIZABLE CHIRAL COMPOUND}Polymerizable chiral compound {POLYMERIZABLE CHIRAL COMPOUND}

본 발명은 중합성 키랄 화합물 및 당해 화합물을 함유하는 중합성 액정 조성물, 또한 당해 중합성 액정 조성물의 경화물인 광학 이방체에 관한 것이다.The present invention relates to a polymerizable chiral compound, a polymerizable liquid crystal composition containing the compound, and an optically anisotropic body which is a cured product of the polymerizable liquid crystal composition.

최근, 정보화 사회의 진전에 따라 표시 디스플레이에 필수적인 편향판, 위상차판 등에 사용되는 광학 이방체의 중요성은 점차 높아지고 있다. 광학 이방체에 필요한 광학 특성은 목적에 따라 상이하므로 목적에 맞는 특성을 갖는 화합물이 필요하다. 또한, 광학 특성뿐만 아니라 화합물의 중합 속도, 용해성, 융점, 유리 전이점, 중합물의 투명성, 중합물의 기계적 강도 등도 중요한 인자가 된다.In recent years, the importance of the optically anisotropic body used for the deflection plate, phase difference plate, etc. which is essential for a display display according to the progress of the information society is increasing. Since the optical properties required for the optically anisotropic body are different depending on the purpose, a compound having properties suitable for the purpose is required. In addition, not only the optical properties but also the polymerization rate, solubility, melting point, glass transition point, transparency of the polymer, mechanical strength of the polymer, etc. are important factors.

최근, 중합성 콜레스테릭 액정을 사용한 원편광 분리 기능 소자가, 휘도 향상 필름으로서 활용되고 있다. 콜레스테릭 액정은 통상, 네마틱 액정에 광학 활성 화합물(이하, 키랄 화합물)을 첨가하는 것에 의해 조제할 수 있다. 액정 디바이스의 광학 보상 필름으로서, 자외선 영역으로부터 가시 광선 영역까지의 원편광 분리 기능을 얻기 위해서는, 매우 피치(p)가 짧은 나선 구조를 필요로 한다. 분자 나선의 피치 p는, 식 (a)에 따라, 액정 조성물에 있어서의 키랄 화합물의 농도 c에 반비례한다. 비례 정수는 키랄 화합물의 나선 비틀림력(HTP)이다. 짧은 피치값을 얻기 위해서는, 키랄 화합물의 농도를 늘리거나, 비틀림력을 강하게 하면 얻어진다.In recent years, the circularly polarized light separating function element using a polymeric cholesteric liquid crystal is utilized as a brightness improving film. A cholesteric liquid crystal can be normally prepared by adding an optically active compound (henceforth a chiral compound) to a nematic liquid crystal. As an optical compensation film of a liquid crystal device, in order to obtain the circularly polarized light separation function from an ultraviolet region to a visible light region, a spiral structure with a very short pitch p is required. The pitch p of a molecular helix is inversely proportional to the density | concentration c of a chiral compound in a liquid crystal composition according to Formula (a). The proportional integer is the helix torsional force (HTP) of the chiral compound. In order to obtain a short pitch value, it is obtained by increasing the concentration of the chiral compound or by increasing the torsional force.

Figure pat00001
Figure pat00001

그러나 키랄 화합물을 많이 배합하게 되면 액정성, 용해성, 중합물의 투명성 등의 광학 특성의 저하나, 고가인 키랄 화합물에 의한 고코스트화 때문에 바람직하지 않다. 따라서 HTP가 강한 키랄 화합물을 사용한 액정 조성물이 바람직하다. 이러한 강한 HTP를 나타내는 화합물로서 환 구조의 광학 활성 부위를 갖는 키랄 화합물이 제안되어 있다(인용문헌 1 및 2 참조). 이들 인용문헌에는 1,4:3,6-디안하이드로-D-만니톨(이소만나이드), 디안하이드로-D-글루시톨(이소소르바이드), 비나프톨 등의 광학 활성 화합물에 기초하는 강한 HTP를 갖는 중합성 키랄 화합물이 개시되어 있다. 그러나, 이들 광학 활성 화합물은 융점이 높고 용해성이 나빠, 일부 액정 화합물과의 상용성(相溶性)이 낮은 등의 문제가 있었다(인용문헌 1). 또한, 용해성을 향상시키기 위해서 구조를 비대칭으로 한 화합물은, 용해성의 점에서는 어느 정도의 개선이 보이지만, 제조가 번잡하기 때문에 제조 코스트가 높아, 광학 이방성체의 고가격화의 요인이 되는 문제가 있었다(인용문헌 2).However, when a large amount of a chiral compound is blended, it is not preferable because of lowering optical properties such as liquid crystallinity, solubility, transparency of the polymer, and high cost of the chiral compound. Therefore, the liquid crystal composition using the chiral compound with strong HTP is preferable. As a compound which shows such a strong HTP, the chiral compound which has the optically active site of ring structure is proposed (refer the citation documents 1 and 2). These citations include strong HTPs based on optically active compounds such as 1,4: 3,6- dianhydro-D-mannitol (isomannide), dianhydro-D-glucinitol (isosorbide), and vinaphthol. A polymerizable chiral compound having is disclosed. However, these optically active compounds had problems such as high melting point, poor solubility, and low compatibility with some liquid crystal compounds (Citation Document 1). In addition, the compound having an asymmetrical structure in order to improve solubility shows some improvement in terms of solubility, but has a problem in that manufacturing cost is high due to complicated manufacturing, which causes a high cost of the optically anisotropic substance ( Citations 2).

일본국 특표평9-506088호 공보Japanese Patent Application Laid-Open No. 9-506088 일본국 특개2003-137887호 공보Japanese Patent Application Laid-Open No. 2003-137887

본 발명이 해결하고자 하는 과제는, 강한 HTP를 갖는 용해성이 우수한 중합성 키랄 화합물을 제공하는 것이다.An object of the present invention is to provide a polymerizable chiral compound excellent in solubility having strong HTP.

본원 발명자들은 중합성 화합물에 있어서의 다양한 치환기의 검토를 행한 결과, 특정한 구조를 갖는 중합성 화합물이 전술한 과제를 해결할 수 있는 것을 발견하여, 본원 발명을 완성하기에 이르렀다.MEANS TO SOLVE THE PROBLEM As a result of studying the various substituents in a polymeric compound, this inventor discovered that the polymeric compound which has a specific structure can solve the above-mentioned subject, and came to complete this invention.

본원 발명은, 일반식 (Ⅰ)This invention is general formula (I)

Figure pat00002
Figure pat00002

(단, R1 및 R2는 서로 독립하여 이하의 식 (R-1) 내지 식 (R-15) 중 어느 하나를 나타내며,(Wherein R 1 and R 2 independently of one another represent any one of the following formulas (R-1) to (R-15),

Figure pat00003
Figure pat00003

A1, A2, A3 및 A4는 서로 독립하여 1,4-페닐렌기, 나프탈렌-2,6-디일기, 1,4-시클로헥실렌기 또는 피리딘-2,5-디일기를 나타내고, A1, A2, A3 및 A4에 포함되는 수소 원자는 서로 독립하여 알킬기, 할로겐화 알킬기, 알콕시기, 할로겐, 시아노기 또는 니트로기에 의해 치환되어 있어도 되고, B1 및 B2는 서로 독립하여, -O-, -S-, -OCH2-, -CH2O-, -CO-, -COO-, -OCO-, -OCOO-, -CO-NR11-, -NR11-CO-, -SCH2-, -CH2S-, -CH=CH-COO-, -OCO-CH=CH-, -COO-CH=CH-, -CH=CH-OCO-, -CH2CH2-COO-, -COO-CH2CH2-, -CH2CH2-OCO-, -OCO-CH2CH2-, -C≡C- 또는 단결합을 나타내고(단, R11은 수소 원자 또는 탄소수 1~4의 알킬기를 나타낸다), Z1은, -COO-, -CH=CH-COO-, -CH2CH2-COO-, -CH2O- 또는 -CF2O-을 나타내고, Z2는, -OCO-, -OCO-CH=CH-, -OCO-CH2CH2-, -OCH2- 또는 -OCF2-를 나타내고, Z는 이하의 일반식 (Z-1) 내지 (Z-3)으로 표시되는 2가의 치환기 중 어느 하나를 나타내고,A 1 , A 2 , A 3 and A 4 independently of each other represent a 1,4-phenylene group, a naphthalene-2,6-diyl group, a 1,4-cyclohexylene group or a pyridine-2,5-diyl group And hydrogen atoms contained in A 1 , A 2 , A 3, and A 4 may be each independently substituted with an alkyl group, a halogenated alkyl group, an alkoxy group, a halogen, a cyano group, or a nitro group, and B 1 and B 2 may be independent from each other. -O-, -S-, -OCH 2- , -CH 2 O-, -CO-, -COO-, -OCO-, -OCOO-, -CO-NR 11- , -NR 11 -CO- , -SCH 2- , -CH 2 S-, -CH = CH-COO-, -OCO-CH = CH-, -COO-CH = CH-, -CH = CH-OCO-, -CH 2 CH 2- COO-, -COO-CH 2 CH 2- , -CH 2 CH 2 -OCO-, -OCO-CH 2 CH 2- , -C≡C- or a single bond (wherein R 11 represents a hydrogen atom or carbon number) 1-4 represents an alkyl group), Z 1 is, -COO-, -CH = CH-COO- , -CH 2 CH 2 -COO-, -CH 2 O- or -CF represents 2 O-, Z 2 Represents -OCO-, -OCO-CH = CH-, -OCO-CH 2 CH 2- , -OCH 2 -or -OCF 2- , Z represents the following general formulas (Z-1) to (Z- 3) as mark It represents any one of divalent substituents,

Figure pat00004
Figure pat00004

(식 중, 각 치환기는 점선으로 표시되는 결합의 한쪽에서 Z1에 다른 쪽에서 Z2와 결합하는 것을 나타내고 있고, Y1, Y2, Y3, Y4, Y5 및 Y6은, 각각 독립하여 탄소수 1~10의 알킬기, 탄소수 1~10의 알콕시기 및 수소 원자를 나타내고, 식 중의 일반식 (Z-1) 내지 (Z-3)으로 표시되는 2가의 치환기는 단일한 입체 구조를 나타낸다) m 및 n은 서로 독립하여, 0, 1 또는 2를 나타내지만, A1, A2, B1 또는/및 B2가 복수 존재할 경우 그들은 서로 독립하여 동일해도 상이해도 된다)로 표시되는 중합성 키랄 화합물을 제공하고, 당해 화합물을 구성 부재로 하는 중합성 조성물, 또한 당해 중합성 조성물을 사용한 광학 이방체를 제공한다.(In the formulas, each substituent indicates bonding to Z 1 on one side of the bond represented by a dotted line and Z 2 on the other side, and Y 1 , Y 2 , Y 3 , Y 4 , Y 5, and Y 6 are each independently. To an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, and a hydrogen atom, and the divalent substituent represented by general formulas (Z-1) to (Z-3) in the formula represents a single three-dimensional structure) m and n, independently of each other, represent 0, 1 or 2, but when a plurality of A 1 , A 2 , B 1 or / and B 2 are present, they may be the same as or different from each other independently; Provided is a compound, a polymerizable composition comprising the compound as a constituent member, and an optically anisotropic body using the polymerizable composition.

본원 발명의 중합성 키랄 화합물은, 강한 HTP 및 낮은 융점을 갖고, 저융점이기 때문에 다른 액정 화합물과의 우수한 용해성을 갖고 중합성 액정 조성물의 구성 부재로서 유용하다. 또한, 제조 방법도 간편하기 때문에 저가로 제조할 수 있는 메리트도 있다. 본원 발명의 중합성 키랄 화합물은 비틀림력이 강하기 때문에 우수한 광학 특성을 갖는 광학 이방체를 제작할 수 있다. 본원 발명의 광학 이방체는, 편향판, 위상차판, 선택 반사판 등의 용도에 유용하다.Since the polymerizable chiral compound of the present invention has strong HTP and low melting point, and has a low melting point, it has excellent solubility with other liquid crystal compounds and is useful as a structural member of the polymerizable liquid crystal composition. In addition, there is a merit that can be manufactured at low cost because the production method is simple. Since the polymeric chiral compound of this invention has a strong torsional force, the optically anisotropic body which has the outstanding optical characteristic can be manufactured. The optically anisotropic body of this invention is useful for uses, such as a deflection plate, retardation plate, and a selective reflection plate.

일반식 (I)에 있어서, R1 및 R2는 서로 독립하여 중합성기를 나타내지만, 중합성기의 구체적인 예로서는, 하기에 나타내는 구조가 예시된다.In general formula (I), although R <1> and R <2> represent a polymeric group independently from each other, the structure shown below is illustrated as a specific example of a polymeric group.

Figure pat00005
Figure pat00005

이들 중합기는 라디칼 중합, 라디칼 부가 중합, 양이온 중합, 및 음이온 중합에 의해 경화한다. 특히 중합 방법으로서 자외선 중합을 행할 경우에는, 식 (R-1), 식 (R-2), 식 (R-4), 식 (R-5), 식 (R-7), 식 (R-11), 식 (R-13) 또는 식 (R-15)가 바람직하고, 식 (R-1), 식 (R-2), 식 (R-7), 식 (R-11) 또는 식 (R-13)이 보다 바람직하고, 식 (R-1) 또는 식 (R-2)가 보다 바람직하다.These polymerizers are cured by radical polymerization, radical addition polymerization, cationic polymerization, and anionic polymerization. In particular, when the ultraviolet polymerization is carried out as the polymerization method, the formula (R-1), formula (R-2), formula (R-4), formula (R-5), formula (R-7), and formula (R- 11), formula (R-13) or formula (R-15) are preferable, and formula (R-1), formula (R-2), formula (R-7), formula (R-11) or formula (R-11) R-13) is more preferable, and a formula (R-1) or a formula (R-2) is more preferable.

A1, A2, A3 및 A4는 독립하여 1,4-페닐렌기 및 나프탈렌-2,6-디일기, 1,4-시클로헥실렌기 또는 피리딘-2,5-디일기를 나타내고, A1, A2, A3 및 A4는 서로 독립하여 알킬기, 할로겐화 알킬기, 알콕시기, 할로겐, 시아노기 또는 니트로기에 의해 치환되어 있어도 되지만, 강한 HTP, 용해성의 면에서, 1,4-페닐렌기, 나프탈렌-2,6-디일기 또는 피리딘-2,5-디일기가 바람직하고, 1,4-페닐렌기 또는 나프탈렌-2,6-디일기가 보다 바람직하고, 치환기로서는, 할로겐, 탄소수 1~4의 알킬기 및 알콕시기가 바람직하다.A 1 , A 2 , A 3 and A 4 independently represent a 1,4-phenylene group and a naphthalene-2,6-diyl group, a 1,4-cyclohexylene group or a pyridine-2,5-diyl group, A 1 , A 2 , A 3 and A 4 may be independently substituted with an alkyl group, a halogenated alkyl group, an alkoxy group, a halogen, a cyano group or a nitro group, but in terms of strong HTP and solubility, the 1,4-phenylene group , Naphthalene-2,6-diyl group or pyridine-2,5-diyl group is preferable, 1,4-phenylene group or naphthalene-2,6-diyl group is more preferable, As a substituent, it is halogen, C1-C1- The alkyl group and alkoxy group of 4 are preferable.

B1 및 B2는 서로 독립하여, -O-, -S-, -OCH2-, -CH2O-, -CO-, -COO-, -OCO-, -OCOO-, -CO-NR11-, -NR11-CO-, -SCH2-, -CH2S-, -CH=CH-COO-, -OCO-CH=CH-, -CH2CH2-COO-, -OOC-CH2CH2-, -CH2CH2-OCO-, -OCO-CH2CH2-, -C≡C- 또는 단결합을 나타내지만, -OCH2-, -CH2O-, -COO-, -OCO-, -CH=CH-COO-, -OCO-CH=CH-, -CH2CH2-COO-, -OOC-CH2CH2-, -CH2CH2-OCO-, -OCO-CH2CH2-, -C≡C- 또는 단결합이 바람직하고, -OCH2-, -CH2O-, -COO-, -OCO-, -CH=CH-COO-, -OCO-CH=CH- 또는 단결합이 보다 바람직하다.B 1 and B 2 are each independently of the other -O-, -S-, -OCH 2- , -CH 2 O-, -CO-, -COO-, -OCO-, -OCOO-, -CO-NR 11 -, -NR 11 -CO-, -SCH 2- , -CH 2 S-, -CH = CH-COO-, -OCO-CH = CH-, -CH 2 CH 2 -COO-, -OOC-CH 2 CH 2- , -CH 2 CH 2 -OCO-, -OCO-CH 2 CH 2- , -C≡C- or a single bond, but -OCH 2- , -CH 2 O-, -COO-,- OCO-, -CH = CH-COO-, -OCO-CH = CH-, -CH 2 CH 2 -COO-, -OOC-CH 2 CH 2- , -CH 2 CH 2 -OCO-, -OCO-CH 2 CH 2- , -C≡C- or a single bond is preferred, -OCH 2- , -CH 2 O-, -COO-, -OCO-, -CH = CH-COO-, -OCO-CH = CH -Or a single bond is more preferable.

Z1은, -COO-, -CH=CH-COO-, -CH2CH2-COO-, -CH2O- 또는 -CF2O-을 나타내고, Z2는, -OCO-, -OCO-CH=CH-, -OCO-CH2CH2-, -OCH2- 또는 -OCF2-을 나타내지만, 분자의 강직성을 높이고, HTP를 강하게 하기 위해서는, Z1은 -COO- 또는 -CH=CH-COO-가 바람직하고, Z2는 -OCO- 또는 -OCO-CH=CH-가 바람직하다. Z1 및 Z2는 동일해도 상이해도 되지만, 동일한 편이 제조 공정이 간략하여 바람직하다.Z 1 represents -COO-, -CH = CH-COO-, -CH 2 CH 2 -COO-, -CH 2 O-, or -CF 2 O-, and Z 2 represents -OCO- or -OCO- CH = CH-, -OCO-CH 2 CH 2 -, -OCH 2 - or -OCF 2 - represents the, in order to increase the rigidity of the molecule, strongly HTP, Z 1 is -COO- or -CH = CH -COO- are preferred, Z 2 is preferably -OCO- or -OCO-CH = CH-. Although Z <1> and Z <2> may be same or different, the same one is preferable because the manufacturing process is simple.

Z는 이하의 일반식 (Z-1) 내지 식 (Z-3)으로 표시되는 2가의 치환기 중 어느 하나를 나타내지만, 일반식 (Z-1) 또는 (Z-3)으로 표시되는 2가의 치환기가 보다 바람직하다.Z represents any of the divalent substituents represented by the following General Formulas (Z-1) to (Z-3), but is a divalent substituent represented by General Formula (Z-1) or (Z-3). Is more preferable.

Figure pat00006
Figure pat00006

또, 일반식 (Z-3)으로 표시되는 2가의 치환기는 축 비대칭인 화합물이다. 또한 일반식 (Z-1) 또는 (Z-3)으로 표시되는 2가의 치환기는 실질적으로 단일 이성체를 나타낸다.Moreover, the bivalent substituent represented by general formula (Z-3) is a compound which is axial asymmetric. In addition, the divalent substituent represented by general formula (Z-1) or (Z-3) represents a substantially single isomer.

m 및 n은 0, 1 또는 2를 나타내지만, m 및 n은 0 또는 1이 바람직하다.m and n represent 0, 1 or 2, but m and n are preferably 0 or 1.

A1, A2, B1 또는/및 B2가 복수 존재할 경우 그들은 서로 독립하여 동일해도 상이해도 된다.When two or more A <1> , A <2> , B <1> and / or B <2> exist, they may mutually be same or different independently.

또한 본 발명의 일반식 (I)로 표시되는 중합성 키랄 화합물은 환(環)골격과 중합성기가 직접 결합되어 있기 때문에, 메소겐 부위의 강직성이 증가해 높은 HTP가 얻어진다. 또한, 용해성도 개선되어 당해 액정 조성물에 의한 광학 이방체는 뛰어난 반사 특성을 가진다. 본 발명은, 당해 화합물, 및 구성 부재로 하는 액정 조성물, 또한 당해 액정 조성물을 사용한 광학 이방체를 제공한다.In addition, since the polymerizable chiral compound represented by the general formula (I) of the present invention is directly bonded to the ring skeleton and the polymerizable group, the rigidity of the mesogen moiety increases, and high HTP is obtained. Moreover, solubility is also improved and the optically anisotropic body by the said liquid crystal composition has the outstanding reflection characteristic. This invention provides the compound, the liquid crystal composition used as a structural member, and the optically anisotropic body using the said liquid crystal composition.

일반식 (I)로 표시되는 화합물은, 보다 구체적으로는, 하기의 식 (I-1)~일반식 (I-38)로 표시되는 화합물이 바람직하다.As for the compound represented by general formula (I), the compound represented by following formula (I-1)-general formula (I-38) more specifically is preferable.

Figure pat00007
Figure pat00007

Figure pat00008
Figure pat00008

Figure pat00009
Figure pat00009

Figure pat00010
Figure pat00010

Figure pat00011
Figure pat00011

식 (I-21)~(I-24) 및 (I-37)에는 R체 및 S체가 있지만 비틀림력은 동일하므로, 특정한 용도 이외에서는 어느 쪽이어도 상관없다. 본 발명의 화합물은 이하에 기재하는 합성 방법으로 합성할 수 있다.Formulas (I-21) to (I-24) and (I-37) have R bodies and S bodies, but the torsional forces are the same, so any of them may be used except for specific applications. The compound of this invention can be synthesize | combined by the synthesis method described below.

(제법 1) 일반식 (I-3)으로 표시되는 화합물의 제조(Manufacture method 1) Preparation of the compound represented by general formula (I-3)

4-벤질옥시-3-클로로벤조산과 이소소르바이드((3s, 3aα,6aα)-헥사하이드로프로[3,2-b]푸란-3α,6β-디올)의 디시클로헥실카르보디이미드(DCC) 등의 탈수 축합제 및 촉매로서 N,N-디메틸-4-아미노피리딘(DMAP) 등을 사용한 에스테르화 반응에 의해 얻어지는 식 (S-1)로 표시되는 화합물을, 팔라듐카본에 의한 접촉 수소 환원에 의해 벤질기를 탈리시켜서 식 (S-2)로 표시되는 이소소르바이드 유도체를 얻는다. 또한 메타크릴산 클로라이드와의 에스테르화 반응에 의해, 식 (I-3)으로 표시되는 목적 화합물을 얻을 수 있다.Dicyclohexylcarbodiimide (DCC) of 4-benzyloxy-3-chlorobenzoic acid and isosorbide ((3s, 3aα, 6aα) -hexahydropro [3,2-b] furan-3α, 6β-diol) The compound represented by the formula (S-1) obtained by esterification using N, N-dimethyl-4-aminopyridine (DMAP) or the like as a dehydrating condensing agent such as a catalyst is subjected to catalytic hydrogen reduction by palladium carbon. To desorb the benzyl group to obtain an isosorbide derivative represented by the formula (S-2). Moreover, the target compound represented by Formula (I-3) can be obtained by esterification with methacrylic acid chloride.

Figure pat00012
Figure pat00012

(제법 2) 일반식 (I-8)로 표시되는 화합물의 제조(Manufacture method 2) Preparation of the compound represented by general formula (I-8)

4'-벤질옥시비페닐카르복시산과 이소소르바이드의 DCC 등의 탈수 축합제를 사용한 에스테르화 반응에 의해 얻어지는 식 (S-3)로 표시되는 화합물을, 팔라듐카본(Pd/C)에 의한 접촉 수소 환원에 의해 벤질기를 탈리시켜서 식 (S-4)로 표시되는 이소소르바이드 유도체를 얻는다. 또한 메타크릴산 클로라이드와의 에스테르화 반응에 의해, 식 (I-8)로 표시되는 목적 화합물을 얻을 수 있다.Contact hydrogen by palladium carbon (Pd / C) with the compound represented by Formula (S-3) obtained by esterification using 4'-benzyloxybiphenylcarboxylic acid and dehydrating condensing agent, such as DCC of isosorbide. The benzyl group is released by reduction to obtain an isosorbide derivative represented by the formula (S-4). Moreover, the target compound represented by Formula (I-8) can be obtained by esterification with methacrylic acid chloride.

Figure pat00013
Figure pat00013

(제법 3) 일반식 (I-14)로 표시되는 화합물의 제조(Manufacture method 3) Preparation of the compound represented by general formula (I-14)

4-벤질옥시벤조산과 이소소르바이드의 DCC 등의 탈수 축합제를 사용한 에스테르화 반응에 의해 얻어지는 식 (S-5)로 표시되는 화합물을, Pd/C에 의한 접촉 수소 환원에 의해 벤질기를 탈리시켜서 식 (S-6)으로 표시되는 이소소르바이드 유도체를 얻는다.The compound represented by the formula (S-5) obtained by the esterification reaction using a dehydrating condensing agent such as DCC of 4-benzyloxybenzoic acid and isosorbide is desorbed from the benzyl group by catalytic hydrogen reduction with Pd / C. An isosorbide derivative represented by formula (S-6) is obtained.

Figure pat00014
Figure pat00014

다음으로, 4-하이드록시신남산의 테트라하이드로피라닐에테르 화합물과 식 (S-6)으로 표시되는 화합물의 DCC 등의 탈수 축합제를 사용한 에스테르화 반응에 의해 이소소르바이드 유도체를 얻는다. 또한 이소소르바이드 유도체를 테트라하이드로푸란(THF)/염산으로 탈보호를 행해 식 (S-7)로 표시되는 이소소르바이드 유도체를 얻고, 아크릴산 클로라이드와의 에스테르화 반응에 의해, 식 (I-14)로 표시되는 목적 화합물을 얻을 수 있다.Next, an isosorbide derivative is obtained by esterification using a tetrahydropyranyl ether compound of 4-hydroxycinnamic acid and a dehydrating condensing agent such as DCC of the compound represented by formula (S-6). Furthermore, the isosorbide derivative is deprotected with tetrahydrofuran (THF) / hydrochloric acid to obtain an isosorbide derivative represented by the formula (S-7), and the esterification reaction with acrylic acid chloride gives the formula (I-14). The target compound represented by) can be obtained.

Figure pat00015
Figure pat00015

(제법 4) 일반식 (I-17)로 표시되는 화합물의 제조(Manufacture method 4) Preparation of the compound represented by general formula (I-17)

4-브로모벤조산메틸과 트리메틸실릴아세틸렌의 소노가시라 반응에 의해 식 (S-7)로 표시되는 트리메틸실릴아세틸렌 유도체를 합성한 후, 테트라부틸암모늄플루오라이드에 의해 트리메틸실릴기(TMS)를 탈리시켜서, 식 (S-8)로 표시되는 아세틸렌 유도체를 얻는다. 또한, 4-브로모-2-플루오로페놀의 테트라하이드로피라닐에테르 화합물과의 소노가시라 반응에 의해 식 (S-9)로 표시되는 톨란 유도체를 얻고, 다음으로 수산화나트륨에 의한 가수 분해에 의해 톨란 골격을 갖는 식 (S-10)으로 표시되는 벤조산 유도체를 얻는다.After the trimethylsilylacetylene derivative represented by the formula (S-7) was synthesized by the sonogashi reaction of methyl 4-bromobenzoate and trimethylsilylacetylene, the trimethylsilyl group (TMS) was desorbed by tetrabutylammonium fluoride. And the acetylene derivative represented by formula (S-8). Furthermore, a tolan derivative represented by the formula (S-9) was obtained by a sonogashira reaction of 4-bromo-2-fluorophenol with a tetrahydropyranylether compound, followed by hydrolysis with sodium hydroxide. A benzoic acid derivative represented by formula (S-10) having a tolan skeleton is obtained.

Figure pat00016
Figure pat00016

톨란 골격을 갖는 식 (S-10)으로 표시되는 벤조산 유도체와 이소소르바이드를 DCC 등의 탈수 축합제를 사용한 에스테르화 반응에 의해 이소소르바이드 유도체를 얻고, 또한 이소소르바이드 유도체를 THF/염산으로 탈보호를 행해 식 (S-11)로 표시되는 이소소르바이드 유도체를 얻는다.An isosorbide derivative is obtained by esterification of a benzoic acid derivative represented by formula (S-10) having a tolan skeleton with isosorbide using a dehydrating condensing agent such as DCC, and an isosorbide derivative is converted into THF / hydrochloric acid. Deprotection is performed to obtain an isosorbide derivative represented by formula (S-11).

다음으로 메타크릴산 클로라이드와의 에스테르화 반응에 의해, 식 (I-17)로 표시되는 목적 화합물을 얻을 수 있다.Next, the target compound represented by Formula (I-17) can be obtained by esterification with methacrylic acid chloride.

Figure pat00017
Figure pat00017

(제법 5) 일반식 (I-23)으로 표시되는 화합물의 제조(Manufacture method 5) Preparation of the compound represented by general formula (I-23)

비나프톨과 아세톡시벤조산의 디시클로헥실카르보디이미드 등의 탈수 축합제를 사용한 에스테르화 반응에 의해 비나프틸 유도체 (S-12)를 얻은 후, 부틸아민에 의해 아세틸기를 탈리시켜서 하이드록시벤조산 유도체 (S-13)를 얻는다. 다음으로, 하이드록시벤조산 유도체 (S-14)와 4-아크릴로일옥시벤조산의 디시클로헥실카르보디이미드 등의 탈수 축합제를 사용한 에스테르화 반응에 의해 목적물 화합물 (I-23)을 얻을 수 있다.Binaphthyl derivative (S-12) was obtained by esterification using a dehydrating condensing agent such as dicyclohexylcarbodiimide of vinaptol and acetoxybenzoic acid, and then acetyl group was removed by butylamine to decompose the hydroxybenzoic acid derivative. Obtain (S-13). Next, the target compound (I-23) can be obtained by esterification using a dehydrating condensing agent such as hydroxybenzoic acid derivative (S-14) and dicyclohexylcarbodiimide of 4-acryloyloxybenzoic acid. .

Figure pat00018
Figure pat00018

(제법 6) 일반식 (I-25)로 표시되는 화합물의 제조(Manufacture method 6) Preparation of the compound represented by general formula (I-25)

타르타르산에틸과 4-아크릴로일옥시벤조산을 디시클로헥실카르보디이미드 등의 탈수 축합제를 사용한 에스테르화 반응에 의해 목적물 화합물 (I-25)을 얻을 수 있다.Target compound (I-25) can be obtained by esterification of ethyl tartrate and 4-acryloyloxybenzoic acid using dehydrating condensing agents such as dicyclohexylcarbodiimide.

Figure pat00019
Figure pat00019

(제법 7) 일반식 (I-38)로 표시되는 화합물의 제조(Manufacture method 7) Preparation of the compound represented by general formula (I-38)

타르타르산에틸과 아세톡시나프토산의 디시클로헥실카르보디이미드 등의 탈수 축합제를 사용한 에스테르화 반응, 또한 부틸아민을 사용한 탈아세틸기 반응에 의해, 나프토산 유도체 (S-14)를 얻는다. 다음으로, 말레이미드아세트산과의 디시클로헥실카르보디이미드 등의 탈수 축합제를 사용한 에스테르화 반응에 의해 목적 화합물 (I-38)을 얻을 수 있다.A naphthoic acid derivative (S-14) is obtained by esterification using a dehydrating condensing agent such as dicyclohexylcarbodiimide of ethyl tartrate and acetoxynaphthoic acid, and deacetyl group reaction using butylamine. Next, the target compound (I-38) can be obtained by esterification using dehydrating condensing agents such as dicyclohexylcarbodiimide with maleimide acetic acid.

Figure pat00020
Figure pat00020

본원 발명의 중합성 화합물은, 키랄 네마틱, 키랄 스멕틱 및 콜레스테릭 액정 조성물에 호적(好適)하게 사용할 수 있다. 본원 발명의 화합물을 구성 부재로 하는 액정 조성물에 있어서, 중합성 키랄 화합물의 첨가량은, 0.1~40질량%가 바람직하고 3~25질량%가 보다 바람직하다.The polymeric compound of this invention can be used suitably for a chiral nematic, a chiral smectic, and a cholesteric liquid crystal composition. In the liquid crystal composition which uses the compound of this invention as a structural member, 0.1-40 mass% is preferable and, as for the addition amount of a polymeric chiral compound, 3-25 mass% is more preferable.

본원 발명의 중합성 키랄 화합물을 함유하는 중합성 조성물은 액정성을 나타내도 나타내지 않아도 되지만, 액정성을 나타내는 것이 바람직하고, 그 구성으로서는, 일반식 (I)로 표시되는 화합물을 함유하는 이외에 제한은 없지만, 조합시켜서 사용하는 중합성 화합물로서는, 화합물 중에 아크릴로일옥시기(R-1) 또는 메타아크릴로일옥시기(R-2)를 갖는 것이 바람직하고, 중합성 관능기를 분자 내에 2개 이상 갖는 것이 보다 바람직하다.Although the polymeric composition containing the polymeric chiral compound of this invention does not need to show or show liquid crystallinity, it is preferable to show liquid crystallinity, and as a structure, the restriction | limiting other than containing the compound represented by General formula (I) is However, as a polymeric compound used in combination, what has acryloyloxy group (R-1) or a methacryloyloxy group (R-2) in a compound is preferable, and what has two or more polymerizable functional groups in a molecule | numerator More preferred.

조합시켜서 사용하는 중합성 화합물은 액정성을 나타내는 것이 바람직하지만, 구체적으로는 일반식 (Ⅱ)Although it is preferable that the polymeric compound used in combination shows liquid crystallinity, Specifically, general formula (II)

Figure pat00021
Figure pat00021

(단, 식 중 A는, H, F, Cl, CN, SCN, OCF3, 1~12개의 탄소 원자를 갖는 알킬기이며, 당해 알킬기는 산소 원자끼리가 직접 결합하지 않는 것으로서 탄소 원자가 산소 원자, 황 원자, -CO-, -COO-, -OCO-, -OCOO-, -CH=CH-, -C≡C-로 치환되어도 되고, 또는 -L6-S4-R4이며, R3 및 R4는 서로 독립하여, 일반식 (I)에 있어서의 R1과 같은 의미를 나타내고, S3 및 S4는, 서로 독립하여 단결합, 또는 1~12개의 탄소 원자를 갖는 알킬렌기를 나타내고, 여기에서 하나 이상의 -CH2-은, 산소 원자끼리가 직접 결합되지 않는 것으로서 -O-, -COO-, -OCO-, -OCOO-로 치환되어도 되고, L4, L5, 및 L6은 서로 독립하여, 단결합, -O-, -S-, -OCH2-, -CH2O-, -CO-, -COO-, -OCO-, -OCOOCH2-, -CH2OCOO-, -CO-NR11-, -NR11-CO-, -SCH2-, -CH2S-, -CH=CH-COO-, -OOC-CH=CH-, -COOC2H4-, -OCOC2H4-, -C2H4OCO-, -C2H4COO-, -OCOCH2-, -CH2COO-, -CH=CH-, -C2H4-, -CF=CH-, -CH=CF-, -CF2-, -CF2O-, -OCF2-, -CF2CH2-, -CH2CF2-, -CF2CF2- 또는 -C≡C-를 나타내고(식 중, R11은 탄소 원자 1~4의 알킬기를 나타낸다), M3 및 M4는 서로 독립하여, 1,4-페닐렌기, 1,4-시클로헥실렌기, 피리딘-2,5-디일기, 피리미딘-2,5-디일기, 나프탈렌-2,6-디일기, 테트라하이드로나프탈렌-2,6-디일기 또는 1,3-디옥산-2,5-디일기를 나타내지만, M3 및 M4는 서로 독립하여 무치환이거나 또는 알킬기, 할로겐화 알킬기, 알콕시기, 할로겐화 알콕시기, 할로겐 기, 시아노기 또는 니트로기로 치환되어 있어도 되고, p는 0, 1, 2 또는 3을 나타낸다. p가 2 또는 3을 나타낼 경우, 2개 혹은 3개 존재하는 L5 및 M4는 서로 독립하여 동일해도 상이해도 된다)로 표시되는 화합물이 바람직하다.(Wherein A is H, F, Cl, CN, SCN, OCF 3 , an alkyl group having 1 to 12 carbon atoms, and the alkyl group does not directly bond with oxygen atoms, and the carbon atoms are oxygen atoms, sulfur May be substituted with an atom, -CO-, -COO-, -OCO-, -OCOO-, -CH = CH-, -C≡C-, or -L 6 -S 4 -R 4 , R 3 and R 4 independently of each other, represent the same meaning as R 1 in General Formula (I), and S 3 and S 4 independently represent a single bond or an alkylene group having 1 to 12 carbon atoms, and here In one or more -CH 2 -is not directly bonded to the oxygen atoms may be substituted with -O-, -COO-, -OCO-, -OCOO-, L 4 , L 5 , and L 6 are independent of each other Single bond, -O-, -S-, -OCH 2- , -CH 2 O-, -CO-, -COO-, -OCO-, -OCOOCH 2- , -CH 2 OCOO-, -CO- NR 11- , -NR 11 -CO-, -SCH 2- , -CH 2 S-, -CH = CH-COO-, -OOC-CH = CH-, -COOC 2 H 4- , -OCOC 2 H 4 -, -C 2 H 4 OCO-, -C 2 H 4 COO-, -OCOCH 2- , -CH 2 CO O-, -CH = CH-, -C 2 H 4- , -CF = CH-, -CH = CF-, -CF 2- , -CF 2 O-, -OCF 2- , -CF 2 CH 2- , -CH 2 CF 2- , -CF 2 CF 2 -or -C≡C- (wherein R 11 represents an alkyl group having 1 to 4 carbon atoms), M 3 and M 4 are independently of each other, 1,4-phenylene group, 1,4-cyclohexylene group, pyridine-2,5-diyl group, pyrimidine-2,5-diyl group, naphthalene-2,6-diyl group, tetrahydronaphthalene-2, 6-diyl group or 1,3-dioxane-2,5-diyl group, but M 3 and M 4 are independently unsubstituted or substituted with an alkyl group, halogenated alkyl group, alkoxy group, halogenated alkoxy group, halogen group, It may be substituted by the cyano group or the nitro group, and p represents 0, 1, 2 or 3. When p represents 2 or 3, the compound represented by two or three L <5> and M <4> which are independent of each other may be same or different) is preferable.

특히 L4, L5 및 L6이 서로 독립하여, 단결합, -O-, -COO- 또는 -OCO-을 나타내고, M3 및 M4가 서로 독립하여, 1,4-페닐렌기, 1,4-시클로헥실렌기, 피리딘-2,5-디일기, 피리미딘-2,5-디일기 또는 나프탈렌-2,6-디일기로 나타나는 중합성 화합물이 바람직하다.In particular, L 4 , L 5 and L 6 independently of each other, represent a single bond, -O-, -COO- or -OCO-, M 3 and M 4 independently of each other, 1,4-phenylene group, 1, The polymeric compound represented by a 4-cyclohexylene group, a pyridine-2, 5- diyl group, a pyrimidine-2, 5- diyl group, or a naphthalene-2, 6- diyl group is preferable.

일반식 (Ⅱ)로 표시되는 중합성 화합물은 구체적으로는, 일반식 (Ⅱ-1)~일반식 (Ⅱ-22)로 표시되는 화합물이 바람직하다.As for the polymeric compound represented by general formula (II), the compound specifically, represented by general formula (II-1)-general formula (II-22) is preferable.

Figure pat00022
Figure pat00022

Figure pat00023
Figure pat00023

Figure pat00024
Figure pat00024

(식 중, p 및 q는 서로 독립하여 0~12의 정수를 나타내지만, p 및/또는 q가 0일 경우에는 2개의 산소 원자를 직접 결합하는 경우는 없이, 한쪽의 산소 원자를 제거한다)(In formula, p and q represent the integer of 0-12 independently of each other, but when p and / or q are 0, one oxygen atom is removed, without directly bonding two oxygen atoms.)

또한 본원 발명의 중합성 조성물에 사용하는 중합성 액정 화합물로서는, 액정 온도 범위나 복(複)굴절율의 조절, 점도 저감을 목적으로 해서 일반식 (Ⅲ-1)~일반식 (Ⅲ-11)을 배합하는 것이 바람직하다.Moreover, as a polymeric liquid crystal compound used for the polymeric composition of this invention, general formula (III-1)-general formula (III-11) are used for the purpose of adjustment of a liquid crystal temperature range, birefringence, and a viscosity reduction. It is preferable to mix.

Figure pat00025
Figure pat00025

Figure pat00026
Figure pat00026

(식 중, p 및 q는 서로 독립하여 0~12의 정수를 나타내지만, p가 0일 경우에는 2개의 산소 원자를 직접 결합하는 경우는 없이, 한쪽의 산소 원자를 제거한다)(In formula, p and q represent the integer of 0-12 independently of each other, but when p is 0, one oxygen atom is removed, without directly bonding two oxygen atoms.)

또한 본원 발명의 화합물 이외의 키랄 화합물도 첨가해도 되는, 구체적인 화합물로서는 일반식 (Ⅳ-1)~일반식 (Ⅳ-7)로 나타내진다. 키랄 화합물의 배합량은, 액정 조성물에 대해서, 0.5~30질량%가 바람직하고, 2~20질량%가 보다 바람직하다.Moreover, as a specific compound which may also add chiral compounds other than the compound of this invention, it is represented by General formula (IV-1)-general formula (IV-7). 0.5-30 mass% is preferable with respect to a liquid crystal composition, and, as for the compounding quantity of a chiral compound, 2-20 mass% is more preferable.

Figure pat00027
Figure pat00027

(식 중, p 및 q는 서로 독립하여 0~12의 정수를 나타내지만, p 및/또는 q가 0일 경우에는 2개의 산소 원자를 직접 결합하는 경우는 없이, 한쪽의 산소 원자를 제거한다)(In formula, p and q represent the integer of 0-12 independently of each other, but when p and / or q are 0, one oxygen atom is removed, without directly bonding two oxygen atoms.)

또한 본 발명의 액정 조성물로, 중합성기를 갖지 않는 액정 조성물에 첨가해도 되고, 통상의 액정 디바이스, 예를 들면 STN(수퍼·트위스티드·네마틱) 액정이나, TN(트위스티드·네마틱) 액정, TFT(박막 트랜지스터) 액정 등에 사용되는 네마틱 액정 조성물, 강(强)유전 액정 조성물 등이 예시된다.Moreover, you may add to the liquid crystal composition which does not have a polymeric group by the liquid crystal composition of this invention, and a normal liquid crystal device, for example, STN (super twisted nematic) liquid crystal, TN (twisted nematic) liquid crystal, TFT (Thin Film Transistor) Examples of nematic liquid crystal compositions, ferroelectric liquid crystal compositions, and the like used for liquid crystals are illustrated.

또한, 중합성 관능기를 갖는 화합물로서, 액정성을 나타내지 않는 화합물을 첨가할 수도 있다. 이러한 화합물로서는, 통상, 이 기술분야에서 고분자 형성성 모노머 혹은 고분자 형성성 올리고머로서 인식되는 것이면 특별히 제한 없이 사용할 수 있지만, 조성물이 액정상(液晶相)을 띠는 것이 요구될 경우에는, 그 첨가량은 조성물로서 액정성을 띠도록 조정할 필요가 있다.Moreover, as a compound which has a polymeric functional group, the compound which does not show liquid crystallinity can also be added. As such a compound, if it is generally recognized as a polymer-forming monomer or a polymer-forming oligomer in the art, it can be used without particular limitation, but when the composition is required to have a liquid crystal phase, the amount of addition is It is necessary to adjust so that it may be liquid crystalline as a composition.

본 발명의 액정 조성물은, 중합 개시제를 첨가하지 않아도 열 및 광(光)에 의한 중합이 가능하지만, 광중합 개시제의 첨가가 바람직하다. 첨가하는 광중합 개시제의 농도는, 0.1~10질량%가 바람직하고, 0.2~10질량%가 더욱 바람직하고, 0.4~5질량%가 특히 바람직하다. 광 개시제로서는, 벤조인에테르류, 벤조페논류, 아세트페논류, 벤질케탈류, 아실포스핀옥사이드류 등이 예시된다.Although the liquid crystal composition of this invention can superpose | polymerize by heat and light without adding a polymerization initiator, addition of a photoinitiator is preferable. 0.1-10 mass% is preferable, as for the density | concentration of the photoinitiator to add, 0.2-10 mass% is more preferable, and 0.4-5 mass% is especially preferable. Examples of the photoinitiator include benzoin ethers, benzophenones, acetphenones, benzyl ketals, acylphosphine oxides, and the like.

또한, 본 발명의 액정 조성물에는, 그 보존 안정성을 향상시키기 위해서, 안정제를 첨가할 수도 있다. 사용할 수 있는 안정제로서는, 예를 들면 하이드로퀴논류, 하이드로퀴논모노알킬에테르류, 제3부틸카테콜류, 피로갈롤류, 티오페놀류, 니트로 화합물류, β-나프틸아민류, β-나프톨류, 니트로소 화합물 등이 예시된다. 안정제를 사용할 경우의 첨가량은, 액정 조성물에 대해서 0.005~1질량%의 범위가 바람직하고, 0.02~0.5질량%가 더욱 바람직하고, 0.03~0.1질량%가 특히 바람직하다.Moreover, in order to improve the storage stability, you may add a stabilizer to the liquid crystal composition of this invention. Examples of stabilizers that can be used include, for example, hydroquinones, hydroquinone monoalkyl ethers, tertiary butylcatechols, pyrogallols, thiophenols, nitro compounds, β-naphthylamines, β-naphthols and nitrosos. Compounds and the like. The range of 0.005-1 mass% is preferable with respect to a liquid crystal composition, as for the addition amount when using a stabilizer, 0.02-0.5 mass% is more preferable, 0.03-0.1 mass% is especially preferable.

또한 본 발명의 액정 조성물을 위상차 필름, 편광 필름이나 배향막의 원료, 또는 인쇄 잉크 및 도료, 보호막 등의 용도에 이용할 경우에는, 그 목적에 따라 금속, 금속 착체(錯體), 염료, 안료, 색소, 형광 재료, 인광 재료, 계면 활성제, 레벨링제, 틱소제, 겔화제, 다당류, 자외선 흡수제, 적외선 흡수제, 항산화제, 이온 교환 수지, 산화티타늄 등의 금속 산화물 등을 첨가할 수 있다.Moreover, when using the liquid crystal composition of this invention for the use of retardation film, the raw material of a polarizing film, an oriented film, or a printing ink, a coating material, a protective film, etc., according to the objective, it is a metal, a metal complex, dye, a pigment, a pigment. , Fluorescent materials, phosphorescent materials, surfactants, leveling agents, thixotropic agents, gelling agents, polysaccharides, ultraviolet absorbers, infrared absorbers, antioxidants, ion exchange resins, metal oxides such as titanium oxide and the like can be added.

다음으로 본 발명의 광학 이방체에 대해서 설명한다. 본 발명의 액정 조성물을 중합시키는 것에 의해 제조되는 광학 이방체는 다양한 용도에 이용할 수 있다. 예를 들면, 본 발명의 중합성 액정 조성물을 배향시키지 않은 상태로 중합시켰을 경우, 광 산란판, 편광 해소판, 무아레 무늬(moire pattern) 방지판으로서 이용 가능하다. 또한, 본 발명의 중합성 액정 조성물을 배향시킨 상태에 있어서, 중합시키는 것에 의해 제조된 광학 이방체는, 물리적 성질에 광학 이방성을 갖고 있어 유용하다. 이러한 광학 이방체는, 예를 들면 본 발명의 중합성 액정 조성물 표면을, 천 등으로 러빙 처리한 기판, 혹은 유기 박막을 형성한 기판 표면을 천 등으로 러빙 처리한 기판, 혹은 SiO2를 사방(斜方) 증착한 배향막을 갖는 기판 상에 담지(擔持)시키거나, 기판 사이에 협지(挾持)시킨 후, 본 발명의 액정을 중합시키는 것에 의해 제조할 수 있다.Next, the optically anisotropic body of this invention is demonstrated. The optically anisotropic body manufactured by polymerizing the liquid crystal composition of this invention can be used for various uses. For example, when superposing | polymerizing in the state which does not orientate the polymeric liquid crystal composition of this invention, it can use as a light scattering plate, a polarization canceling plate, and a moire pattern prevention plate. Moreover, in the state which orientated the polymerizable liquid crystal composition of this invention, the optically anisotropic body manufactured by superposing | polymerizing has optical anisotropy in physical property, and is useful. Such an optically anisotropic body is, for example, a substrate obtained by rubbing the surface of the polymerizable liquid crystal composition of the present invention with a cloth, or a substrate obtained by rubbing the substrate surface on which the organic thin film is formed with a cloth, or SiO 2 . It can manufacture by carrying out on a board | substrate which has the oriented film deposited, or pinching between board | substrates, and polymerizing the liquid crystal of this invention.

중합성 액정 조성물을 기판 상에 담지시킬 때의 방법으로서는, 스핀 코팅, 다이 코팅, 익스트루전 코팅, 롤 코팅, 와이어 바 코팅, 그라비어 코팅, 스프레이 코팅, 디핑, 프린트법 등이 예시된다. 또한 코팅 시, 중합성 액정 조성물을 그대로 사용해도, 유기 용매를 첨가해도 된다. 유기 용매로서는, 아세트산에틸, 테트라하이드로푸란, 톨루엔, 헥산, 메탄올, 에탄올, 디메틸포름아미드, 디클로로메탄, 이소프로판올, 아세톤, 메틸에틸케톤, 아세트니트릴, 셀로솔브, 시클로헥사논, γ-부틸락톤, 아세톡시-2-에톡시에탄, 프로필렌글리콜모노메틸아세테이트, N-메틸피롤리디논류를 예시할 수 있다. 이들은 단독이어도, 조합시켜서 사용해도 되고, 그 증기압과 중합성 액정 조성물의 용해성을 고려해 적의(適宜) 선택하면 된다. 또한, 그 첨가량은 90질량% 이하가 바람직하다. 첨가한 유기 용매를 휘발시키는 방법으로서는, 자연 건조, 가열 건조, 감압 건조, 감압 가열 건조를 사용할 수 있다. 중합성 액정 재료의 도포성을 더욱 향상시키기 위해서는, 기판 상에 폴리이미드 박막 등의 중간층을 마련하는 것이나, 중합성 액정 재료에 레벨링제를 첨가하는 것도 유효하다. 기판 상에 폴리이미드 박막 등의 중간층을 마련하는 것은, 중합성 액정 재료를 중합시켜서 얻어지는 광학 이방체와 기판의 밀착성이 좋지 않을 경우에, 밀착성을 향상시키는 수단으로서도 유효하다.Examples of the method for supporting the polymerizable liquid crystal composition on the substrate include spin coating, die coating, extrusion coating, roll coating, wire bar coating, gravure coating, spray coating, dipping, printing, and the like. In addition, you may use a polymeric liquid crystal composition as it is at the time of coating, or may add an organic solvent. As the organic solvent, ethyl acetate, tetrahydrofuran, toluene, hexane, methanol, ethanol, dimethylformamide, dichloromethane, isopropanol, acetone, methyl ethyl ketone, acetonitrile, cellosolve, cyclohexanone, γ-butyllactone, ace Oxy-2-ethoxyethane, propylene glycol monomethyl acetate, and N-methylpyrrolidinones can be illustrated. These may be used individually or in combination, What is necessary is just to select suitably in consideration of the vapor pressure and the solubility of a polymeric liquid crystal composition. Moreover, as for the addition amount, 90 mass% or less is preferable. As a method of volatilizing the added organic solvent, natural drying, heat drying, reduced pressure drying, and reduced pressure heating drying can be used. In order to further improve the applicability of the polymerizable liquid crystal material, it is also effective to provide an intermediate layer such as a polyimide thin film on the substrate or to add a leveling agent to the polymerizable liquid crystal material. Providing intermediate | middle layers, such as a polyimide thin film, on a board | substrate is effective also as a means of improving adhesiveness, when adhesiveness of the optically anisotropic body obtained by superposing | polymerizing a polymeric liquid crystal material and a board | substrate is not good.

액정 조성물을 기판 사이에 협지시키는 방법으로서는, 모세관 현상을 이용한 주입법이 예시된다. 기판 사이에 형성된 공간을 감압하고, 그 후 액정 재료를 주입하는 수단도 유효하다.As a method of clamping a liquid crystal composition between board | substrates, the injection method using a capillary phenomenon is illustrated. The means for depressurizing the space formed between the substrates and then injecting the liquid crystal material is also effective.

러빙 처리, 혹은 SiO2의 사방 증착 이외의 배향 처리로서는, 액정 재료의 유동 배향의 이용이나, 전장(電場) 또는 자장(磁場)의 이용을 예시할 수 있다. 이들 배향 수단은 단독으로 사용해도, 또한 조합시켜서 사용해도 된다. 또한, 러빙을 대신하는 배향 처리 방법으로서, 광배향법을 사용할 수도 있다. 이 방법은, 예를 들면 폴리비닐신나메이트 등의 분자 내에 광이량화(光二量化) 반응하는 관능기를 갖는 유기 박막, 광으로 이성화(異性化)하는 관능기를 갖는 유기 박막 또는 폴리이미드 등의 유기 박막에, 편광한 광, 바람직하게는 편광한 자외선을 조사하는 것에 의해, 배향막을 형성하는 것이다. 이 광배향법에 광 마스크를 적용하는 것에 의해 배향의 패턴화를 용이하게 달성할 수 있으므로, 광학 이방체 내부의 분자 배향도 정밀하게 제어하는 것이 가능해진다.Examples of the rubbing treatment or the alignment treatment other than the vapor deposition of SiO 2 include the use of flow orientation of the liquid crystal material and the use of an electric field or a magnetic field. These orientation means may be used independently, or may be used in combination. Moreover, as an orientation processing method which replaces rubbing, the photo-alignment method can also be used. This method is, for example, an organic thin film having a functional group for photodimerization reaction in a molecule such as polyvinyl cinnamate, an organic thin film having a functional group for isomerizing with light or an organic thin film such as polyimide The alignment film is formed by irradiating polarized light, preferably polarized ultraviolet light. By applying a photomask to this photo-alignment method, the patterning of an orientation can be achieved easily, and it becomes possible to precisely control the molecular orientation inside an optically anisotropic body.

기판의 형상으로서는, 평판 외에, 곡면을 구성 부분으로서 갖고 있어도 된다. 기판을 구성하는 재료는, 유기 재료, 무기 재료를 불문하고 사용할 수 있다. 기판의 재료가 되는 유기 재료로서는, 예를 들면 폴리에틸렌테레프탈레이트, 폴리카보네이트, 폴리이미드, 폴리아미드, 폴리메타크릴산메틸, 폴리스티렌, 폴리염화비닐, 폴리테트라플루오로에틸렌, 폴리클로로트리플루오로에틸렌, 폴리아릴레이트, 폴리술폰, 트리아세틸셀룰로오스, 셀룰로오스, 폴리에테르에테르케톤 등이 예시되고, 또한 무기 재료로서는, 예를 들면 실리콘, 유리, 방해석 등이 예시된다.The shape of the substrate may have a curved surface in addition to the flat plate as a constituent portion. The material which comprises a board | substrate can be used regardless of an organic material and an inorganic material. As an organic material used as a material of a board | substrate, for example, polyethylene terephthalate, polycarbonate, polyimide, polyamide, polymethyl methacrylate, polystyrene, polyvinyl chloride, polytetrafluoroethylene, polychlorotrifluoroethylene, Polyarylate, polysulfone, triacetyl cellulose, cellulose, polyether ether ketone and the like are exemplified, and examples of the inorganic material include silicon, glass, calcite and the like.

이들 기판을 천 등으로 러빙하는 것에 의해 적당한 배향성을 얻을 수 없을 경우, 공지의 방법에 따라서 폴리이미드 박막 또는 폴리비닐알코올 박막 등의 유기 박막을 기판 표면에 형성하고, 이것을 천 등으로 러빙해도 된다. 또한, 통상의 TN 액정 디바이스 또는 STN 액정 디바이스에서 사용되고 있는 프리틸트 각을 부여하는 폴리이미드 박막은, 광학 이방체 내부의 분자 배향 구조를 더욱 정밀하게 제어할 수 있는 점에서 특히 바람직하다.If proper orientation cannot be obtained by rubbing these substrates with a cloth or the like, an organic thin film such as a polyimide thin film or a polyvinyl alcohol thin film may be formed on the surface of the substrate in accordance with a known method and then rubbed with a cloth or the like. Moreover, the polyimide thin film which gives the pretilt angle used by a normal TN liquid crystal device or STN liquid crystal device is especially preferable at the point which can control the molecular orientation structure inside an optically anisotropic body more precisely.

또한, 전장에 의해 배향 상태를 제어할 경우에는, 전극층을 갖는 기판을 사용한다. 이 경우, 전극 상에 전술한 폴리이미드 박막 등의 유기 박막을 형성하는 것이 바람직하다.In addition, when controlling an orientation state by electric field, the board | substrate which has an electrode layer is used. In this case, it is preferable to form organic thin films, such as the above-mentioned polyimide thin film, on an electrode.

본 발명의 액정 조성물을 중합시키는 방법으로서는, 신속한 중합의 진행이 바람직하므로, 자외선 또는 전자선 등의 활성 에너지선을 조사하는 것에 의해 중합시키는 방법이 바람직하다. 자외선을 사용할 경우, 편광 광원을 사용해도 되고, 비편광 광원을 사용해도 된다. 또한, 액정 조성물을 2매의 기판 사이에 협지시킨 상태로 중합을 행할 경우에는, 적어도 조사면 측의 기판은 활성 에너지선에 대해서 적당한 투명성이 부여되어 있어야 한다. 또한, 광조사 시에 마스크를 사용해서 특정한 부분만을 중합시킨 후, 전장이나 자장 또는 온도 등의 조건을 변화시키는 것에 의해, 미(未)중합 부분의 배향 상태를 변화시켜서, 활성 에너지선을 더 조사해서 중합시킨다는 수단을 사용해도 된다. 또한, 조사 시의 온도는, 본 발명의 액정 조성물의 액정 상태가 유지되는 온도 범위 내인 것이 바람직하다. 특히, 광중합에 의해 광학 이방체를 제조하고자 할 경우에는, 의도하지 않는 열중합의 유기(誘起)를 피하는 의미에서도 가능한 한 실온에 가까운 온도, 즉 전형적으로는 25℃로의 온도에서 중합시키는 것이 바람직하다. 활성 에너지선의 강도는, 0.1㎽/㎠~2W/㎠가 바람직하다. 강도가 0.1㎽/㎠ 이하일 경우, 광중합을 완료시키는데에 다대(多大)한 시간이 필요하게 되어 생산성이 악화되게 되고, 2W/㎠ 이상일 경우, 중합성 액정 화합물 또는 중합성 액정 조성물이 열화되게 될 위험이 있다.As a method of superposing | polymerizing the liquid crystal composition of this invention, since rapid superposition | polymerization is preferable, the method of superposing | polymerizing by irradiating active energy rays, such as an ultraviolet-ray or an electron beam, is preferable. In the case of using ultraviolet rays, a polarized light source may be used or a non-polarized light source may be used. In addition, when superposing | polymerizing in the state which pinched the liquid crystal composition between two board | substrates, at least the board | substrate by the irradiation surface side should be provided with moderate transparency with respect to active energy ray. Moreover, after polymerizing only a specific part using a mask at the time of light irradiation, the orientation state of an unpolymerized part is changed by changing conditions, such as an electric field, a magnetic field, or temperature, and an active energy ray is irradiated further. You may use the means for making it superpose | polymerize. Moreover, it is preferable that the temperature at the time of irradiation is in the temperature range in which the liquid crystal state of the liquid crystal composition of this invention is maintained. In particular, in the case where the optically anisotropic body is to be produced by photopolymerization, it is preferable to polymerize at a temperature as close to room temperature as possible, that is, typically at a temperature of 25 ° C, even in the sense of avoiding unintentional thermal polymerization. As for the intensity | strength of an active energy ray, 0.1 kW / cm <2> -2W / cm <2> is preferable. When the intensity is 0.1 mW / cm 2 or less, a large amount of time is required to complete the photopolymerization, and the productivity is deteriorated. When the intensity is 2 W / cm 2 or more, the polymerizable liquid crystal compound or the polymerizable liquid crystal composition is deteriorated. There is this.

중합에 의해 얻어지는 본 발명의 광학 이방체는, 초기의 특성 변화를 경감하고, 안정적인 특성 발현을 도모하는 것을 목적으로 해서 열처리를 실시할 수도 있다. 열처리의 온도는 50~250℃의 범위이고, 또한 열처리 시간은 30초~12시간의 범위가 바람직하다.The optically anisotropic body of this invention obtained by superposition | polymerization can also heat-treat for the purpose of reducing initial characteristic change and aiming at stable characteristic expression. The temperature of heat processing is 50-250 degreeC, and the heat processing time of 30 second-12 hours is preferable.

이러한 방법에 의해 제조되는 본 발명의 광학 이방체는, 기판으로부터 박리해서 단체로 사용해도, 박리하지 않고 사용해도 된다. 또한, 얻어진 광학 이방체를 적층해도, 다른 기판에 첩합(貼合)해서 사용해도 된다.The optically anisotropic body of this invention manufactured by such a method may be used alone or peeled off from a board | substrate, or may be used without peeling. Moreover, even if the obtained optically anisotropic body is laminated | stacked, you may bond to another board | substrate and use it.

[실시예][Example]

이하, 실시예를 예시해서 본 발명을 더욱 상술하지만, 본 발명은 이들 실시예에 한정되는 것이 아니다. 또한, 이하의 실시예 및 비교예의 조성물에 있어서의 「%」는 『질량%』를 의미한다.Hereinafter, although an Example is given and this invention is further explained, this invention is not limited to these Examples. In addition, "%" in the composition of the following example and a comparative example means "mass%."

이하, 실시예를 예시해서 본 발명을 더욱 상술하지만, 본 발명은 이들 실시예에 한정되는 것이 아니다. 각종 분석은 이하의 방법에 의해 행했다.Hereinafter, although an Example is given and this invention is further explained, this invention is not limited to these Examples. Various analysis was performed by the following method.

·상전이 온도 : 온도 조절 스테이지를 구비한 편광 현미경으로 측정Phase transition temperature: measured by polarized light microscope equipped with temperature control stage

·화합물의 구조 : 핵 자기 공명 스펙트럼(NMR), 질량 스펙트럼(MS) 등에 의해 확인Structure of compound: confirmed by nuclear magnetic resonance spectrum (NMR), mass spectrum (MS)

이하의 실시예 및 비교예의 조성물에 있어서의 「%」은 『질량%』를 의미한다."%" In the composition of the following example and a comparative example means "mass%."

Tn -i는 네마틱상-등방상의 전이 온도를 나타낸다.T n -i represents the transition temperature of the nematic phase-isotropic phase.

HTP(비틀림력)의 측정 방법 : 중합성 키랄 화합물을 네마틱 액정(DON-103, DIC사제)에 2중량% 첨가한 조성물을 시판의 1축 배향 처리를 행한 쐐기형 셀에 주입하고, 편광 현미경을 사용해서 실온에서 나선 피치를 측정했다. 이 값을 상기 식 (a)에 대입해 HTP를 구했다.Measurement method of HTP (torsional force): A composition obtained by adding 2% by weight of a polymerizable chiral compound to a nematic liquid crystal (DON-103, manufactured by DIC Corporation) was injected into a commercially available wedge-shaped cell subjected to uniaxial alignment treatment, and then polarized light microscope The spiral pitch was measured at room temperature using. This value was substituted into said Formula (a), and HTP was calculated | required.

원편광 특성 : 자외 가시 분광 광도계 U-4100(히타치세이사쿠쇼제)로 450㎚~650㎚의 스펙트럼을 측정Circularly polarized light characteristics: 450 to 650 nm spectrum was measured with an ultraviolet visible spectrophotometer U-4100 (manufactured by Hitachi Seisakusho)

화합물 기재에 하기한 약호를 사용한다.The following symbol is used for a compound base material.

(실시예 1)(Example 1)

교반 장치, 냉각기 및 온도계를 구비한 반응 용기에 3-(p-하이드록시페닐)벤조산 33.2g(240밀리몰), 요오드화칼륨 4g, 테트라부틸암모늄브로마이드 1g, 에탄올 400㎖를 투입해서 실온에서 교반했다. 수산화나트륨 24g의 25% 수용액을 천천히 적하했다. 적하 종료 후, 반응 용기를 50℃로 유지하고, 벤질브로마이드 50g(288밀리몰)을 천천히 적하했다. 적하 종료 후, 반응 용기를 70℃로 더 가온해서 3시간 더 반응시켰다. 반응 종료 후, 10% 염산으로 중화해서 아세트산에틸로 추출을 행하고, 황산나트륨으로 건조 후, 용매를 농축해서 식 (1)로 나타내는 화합물을 38g 합성했다.33.2 g (240 mmol) of 3- (p-hydroxyphenyl) benzoic acid, 4 g of potassium iodide, 1 g of tetrabutylammonium bromide, and 400 ml of ethanol were added to a reaction vessel equipped with a stirring device, a cooler, and a thermometer, followed by stirring at room temperature. A 25% aqueous solution of 24 g of sodium hydroxide was slowly added dropwise. After completion of the dropwise addition, the reaction vessel was maintained at 50 ° C, and 50 g (288 mmol) of benzyl bromide was slowly added dropwise. After completion of the dropwise addition, the reaction vessel was further warmed to 70 ° C and allowed to react for 3 hours. After completion | finish of reaction, it neutralized with 10% hydrochloric acid, extracted with ethyl acetate, dried with sodium sulfate, concentrated the solvent, and synthesize | combined 38g of compounds represented by Formula (1).

Figure pat00028
Figure pat00028

다음으로, 교반 장치, 냉각기 및 온도계를 구비한 반응 용기에, 상기에서 합성한 식 (1)로 나타내는 화합물 28g(123밀리몰), 이소소르바이드 7.7g(55밀리몰), 디메틸아미노피리딘 1.8g, 디클로로메탄 500㎖를 투입하고, 빙냉(氷冷) 배쓰(bath)에서 5℃ 이하로 반응 용기를 유지하고, 질소 가스의 분위기 하에서 디이소프로필카르보디이미드 19g(150밀리몰)을 천천히 적하했다. 적하 종료 후, 반응 용기를 실온으로 되돌려 5시간 반응시켰다. 반응액을 여과한 후, 여과액에 디클로로메탄 200㎖를 가하고, 10% 염산 수용액으로 세정하고, 포화 식염수로 더 세정하고, 유기층을 무수 황산나트륨으로 건조시켰다. 용매를 유거(留去)한 후, 5배량(중량비)의 실리카겔 칼럼에 의해 정제를 행해 식 (2)로 나타내는 화합물 23g을 얻었다.Next, 28 g (123 mmol) of the compound represented by Formula (1) synthesized above, 7.7 g (55 mmol) of isosorbide, 1.8 g of dimethylaminopyridine, dichloro, in a reaction vessel equipped with a stirring device, a cooler, and a thermometer. 500 ml of methane were thrown in, the reaction container was hold | maintained at 5 degrees C or less in an ice-cooling bath, and 19 g (150 mmol) of diisopropyl carbodiimide was slowly dripped under the atmosphere of nitrogen gas. After completion of the dropwise addition, the reaction vessel was returned to room temperature and allowed to react for 5 hours. After the reaction solution was filtered, 200 ml of dichloromethane was added to the filtrate, washed with 10% aqueous hydrochloric acid solution, further washed with saturated brine, and the organic layer was dried over anhydrous sodium sulfate. After distilling off the solvent, the mixture was purified by a silica gel column of 5 times (weight ratio) to obtain 23 g of the compound represented by the formula (2).

Figure pat00029
Figure pat00029

다음으로, 교반 장치를 구비한 오토클레이브 용기에, 상기에서 합성한 식 (2)로 나타내는 화합물 23g(40.5밀리몰), 팔라듐카본 1g, 에탄올 150㎖를 투입하고, 0.1MPa의 수소로 환원 반응(반응 온도 50℃, 3시간)을 행했다. 반응액을 여과한 후, 반응 용매를 유거해서 식 (3)으로 나타내는 화합물 14g을 얻었다.Next, 23 g (40.5 mmol) of the compound represented by Formula (2) synthesized above, 1 g of palladium carbon, and 150 ml of ethanol were added to an autoclave vessel equipped with a stirring device, and the reaction was reduced with 0.1 MPa of hydrogen (reaction). Temperature 50 ° C., 3 hours). After filtering the reaction liquid, the reaction solvent was distilled off and the compound 14g shown by Formula (3) was obtained.

Figure pat00030
Figure pat00030

다음으로, 교반 장치, 냉각기 및 온도계를 구비한 반응 용기에, 상기한 식 (3)으로 나타내는 화합물 4g(10.3밀리몰), 아크릴산 클로라이드 2.26g(25밀리몰), 디클로로메탄 50㎖를 투입하고, 질소 가스 분위기 하에서 반응기를 5℃ 이하로 냉각했다. 다음으로 트리에틸아민 2.5g(25밀리몰)을 천천히 적하했다. 적하 종료 후, 20℃ 이하에서 3시간 반응시켰다. 반응 종료 후, 디클로로메탄을 가하고, 10% 염산 수용액, 순수, 포화 식염수로 유기층을 세정했다. 용매를 유거한 후, 2배량(중량비)의 실리카겔 칼럼에 의해 정제를 행해 식 (4)로 나타내는 목적의 화합물 4.2g을 얻었다.Next, 4 g (10.3 mmol) of the compound represented by the above formula (3), 2.26 g (25 mmol) of acrylic acid chloride, and 50 mL of dichloromethane were added to a reaction vessel equipped with a stirring device, a cooler, and a thermometer, and nitrogen gas. The reactor was cooled to 5 ° C. or less under the atmosphere. Next, triethylamine 2.5g (25 mmol) was dripped slowly. After completion of the dropwise addition, the mixture was reacted at 20 ° C or lower for 3 hours. After the completion of the reaction, dichloromethane was added, and the organic layer was washed with 10% aqueous hydrochloric acid solution, pure water and saturated brine. After distilling off the solvent, the product was purified by a silica gel column having a double amount (weight ratio) to obtain 4.2 g of the target compound represented by Formula (4).

Figure pat00031
Figure pat00031

(물성값)(Property value)

1H-NMR(용매 : 중(重)클로로포름) : δ : 4.05~4.11(m, 4H), 4.67(m, 1H), 5.06(m, 1H), 5.42(m, 1H), 5.49(s, 1H), 6.04(d, 2H), 6.29(m, 2H), 6.65(d, 2H), 7.21~7.26(m, 4H), 8.06(dd, 4H) 1 H-NMR (solvent: heavy chloroform): δ: 4.05 to 4.11 (m, 4H), 4.67 (m, 1H), 5.06 (m, 1H), 5.42 (m, 1H), 5.49 (s, 1H), 6.04 (d, 2H), 6.29 (m, 2H), 6.65 (d, 2H), 7.21-7.26 (m, 4H), 8.06 (dd, 4H)

13C-NMR(용매 : 중클로로포름) : δ : 70.7, 73.4, 74.5, 78.5, 81.1, 86.1, 121.7, 126.9, 127.0, 127.5, 131.3, 133.3, 154.5, 163.8, 164.7, 165.1 13 C-NMR (solvent: heavy chloroform): δ: 70.7, 73.4, 74.5, 78.5, 81.1, 86.1, 121.7, 126.9, 127.0, 127.5, 131.3, 133.3, 154.5, 163.8, 164.7, 165.1

적외 흡수 스펙트럼(IR)(KBr) : 2925, 2855, 1760, 1652~1622, 809Infrared Absorption Spectrum (IR): 2925, 2855, 1760, 1652 ~ 1622, 809

(융점) 125℃(Melting point) 125 ℃

하기에서 나타내는 네마틱 액정 조성물에 식 (4)로 나타내는 화합물을 5.0% 첨가해서 광학 현미경에 의해 구해지는 피치로부터 HTP를 산출한 결과, HTP=31이라는 높은 값을 나타냈다.When 5.0% of the compounds represented by Formula (4) were added to the nematic liquid crystal composition shown below, and HTP was computed from the pitch calculated | required by an optical microscope, the high value of HTP = 31 was shown.

Figure pat00032
Figure pat00032

(실시예 2)(Example 2)

교반 장치, 냉각기 및 온도계를 구비한 반응 용기에, 실시예 1에서 합성한 식 (3)으로 나타내는 화합물 4g(10.3밀리몰), 4-아크릴로일옥시벤조산 4.6g(24밀리몰), 디메틸아미노피리딘 200mg, 디클로로메탄 500㎖를 투입하고, 빙냉 배쓰에서 5℃ 이하로 반응 용기를 유지하고, 질소 가스의 분위기 하에서 디이소프로필카르보디이미드 3.6g(28밀리몰)을 천천히 적하했다. 적하 종료 후, 반응 용기를 실온으로 되돌려 5시간 반응시켰다. 반응액을 여과한 후, 여과액에 디클로로메탄 200㎖를 가하고, 10% 염산 수용액으로 세정하고, 포화 식염수로 더 세정하고, 유기층을 무수황산나트륨으로 건조시켰다. 용매를 유거한 후, 5배량(중량비)의 실리카겔 칼럼에 의해 정제를 행해 식 (5)로 나타내는 목적의 화합물 5.2g을 얻었다.4 g (10.3 mmol) of the compound represented by Formula (3) synthesized in Example 1, 4.6 g (24 mmol) of 4-acryloyloxybenzoic acid and 200 mg of dimethylaminopyridine in a reaction vessel equipped with a stirring device, a cooler and a thermometer. , 500 ml of dichloromethane was added, the reaction vessel was kept at 5 ° C. or lower in an ice-cooled bath, and 3.6 g (28 mmol) of diisopropylcarbodiimide was slowly added dropwise under an atmosphere of nitrogen gas. After completion of the dropwise addition, the reaction vessel was returned to room temperature and allowed to react for 5 hours. After the reaction solution was filtered, 200 ml of dichloromethane was added to the filtrate, washed with 10% aqueous hydrochloric acid solution, further washed with saturated brine, and the organic layer was dried over anhydrous sodium sulfate. After distilling a solvent off, it refine | purified by the silica gel column of 5 times (weight ratio), and obtained the target compound 5.2g shown by Formula (5).

Figure pat00033
Figure pat00033

(물성값)(Property value)

1H-NMR(용매 : 중클로로포름) : δ : 4.05~4.11(m, 4H), 4.67(m, 1H), 5.06(m, 1H), 5.42(m, 1H), 5.49(s, 1H), 6.04(d, 2H), 6.29(m, 2H), 6.65(d, 2H), 7.26~7.37(m, 8H), 8.10(d, 2H), 8.17(d, 2H), 8.24~8.27(m, 4H) 1 H-NMR (solvent: heavy chloroform): δ: 4.05-4.11 (m, 4H), 4.67 (m, 1H), 5.06 (m, 1H), 5.42 (m, 1H), 5.49 (s, 1H), 6.04 (d, 2H), 6.29 (m, 2H), 6.65 (d, 2H), 7.26-7.37 (m, 8H), 8.10 (d, 2H), 8.17 (d, 2H), 8.24-8.27 (m, 4H)

13C-NMR(용매 : 중클로로포름) : δ : 70.7, 73.4, 74.6, 78.5, 81.1, 86.1, 121.8, 121.9, 126.5, 127.0, 127.1, 127.4, 131.4, 131.8, 133.4, 154.5, 163.7, 164.7, 165.1 13 C-NMR (solvent: heavy chloroform): δ: 70.7, 73.4, 74.6, 78.5, 81.1, 86.1, 121.8, 121.9, 126.5, 127.0, 127.1, 127.4, 131.4, 131.8, 133.4, 154.5, 163.7, 164.7, 165.1

적외 흡수 스펙트럼(IR)(KBr) : 2925, 2855, 1760, 1652~1622, 809Infrared Absorption Spectrum (IR): 2925, 2855, 1760, 1652 ~ 1622, 809

(융점) 177℃(Melting point) 177 ° C

실시예 1과 마찬가지로 해서 HTP를 산출한 결과, HTP=42라는 높은 값을 나타냈다.As a result of HTP being calculated in the same manner as in Example 1, a high value of HTP = 42 was shown.

(실시예 3)(Example 3)

교반 장치, 냉각기 및 온도계를 구비한 반응 용기에, 실시예 1에서 합성한 식 (3)으로 나타내는 화합물 4g(10.3밀리몰), 4-(4-메타아크릴로일옥시)페닐신남산 7.4g(24밀리몰), 디메틸아미노피리딘 200mg, 디클로로메탄 500㎖를 투입하고, 빙냉 배쓰에서 5℃ 이하로 반응 용기를 유지하고, 질소 가스의 분위기 하에서 디이소프로필카르보디이미드 3.6g(28밀리몰)을 천천히 적하했다. 적하 종료 후, 반응 용기를 실온으로 되돌려 5시간 반응시켰다. 반응액을 여과한 후, 여과액에 디클로로메탄 200㎖를 가하고, 10% 염산 수용액으로 세정하고, 포화 식염수로 더 세정하고, 유기층을 무수황산나트륨으로 건조시켰다. 용매를 유거한 후, 5배량(중량비)의 실리카겔 칼럼에 의해 정제를 행해 식 (6)로 나타내는 목적의 화합물 6.4g을 얻었다.4 g (10.3 mmol) of the compound represented by Formula (3) synthesized in Example 1 and 7.4 g of 4- (4-methacryloyloxy) phenyl cinnamic acid (24) in a reaction vessel equipped with a stirring device, a cooler, and a thermometer. Mmol), 200 mg of dimethylaminopyridine and 500 ml of dichloromethane were added, the reaction vessel was kept at 5 ° C or lower in an ice-cooled bath, and 3.6 g (28 mmol) of diisopropylcarbodiimide was slowly added dropwise under an atmosphere of nitrogen gas. . After completion of the dropwise addition, the reaction vessel was returned to room temperature and allowed to react for 5 hours. After the reaction solution was filtered, 200 ml of dichloromethane was added to the filtrate, washed with 10% aqueous hydrochloric acid solution, further washed with saturated brine, and the organic layer was dried over anhydrous sodium sulfate. After distilling off the solvent, the product was purified by a silica gel column of 5 times (weight ratio) to obtain 6.4 g of the target compound represented by the formula (6).

Figure pat00034
Figure pat00034

(물성값)(Property value)

1H-NMR(용매 : 중클로로포름) : δ : 1.92(s, 6H), 3.91~3.95(m, 2H), 4.05~4.15(m, 2H), 4.63(m, 1H), 4.98(m, 1H), 5.31~5.39(m, 2H), 5.77(s, 1H), 6.41(s, 2H), 6.44~6.65(m, 4H), 7.22(d, 2H), 7.40~7.70(m, 12H), 7.76~7.85(m, 2H) 1 H-NMR (solvent: heavy chloroform): δ: 1.92 (s, 6H), 3.91-3.95 (m, 2H), 4.05-4.15 (m, 2H), 4.63 (m, 1H), 4.98 (m, 1H ), 5.31-5.39 (m, 2H), 5.77 (s, 1H), 6.41 (s, 2H), 6.44-6.65 (m, 4H), 7.22 (d, 2H), 7.40-7.70 (m, 12H), 7.76-7.85 (m, 2H)

13C-NMR(용매 : 중클로로포름) : δ : 70.3, 73.6, 74.1, 76.7, 81.0, 86.0, 116.9, 117.0, 122.0, 127.4, 127.1, 128.0, 128.7, 133.0, 133.2, 135.7, 137.6, 142.3, 142.4, 145.3, 150.8, 165.7, 165.8, 166.2 13 C-NMR (solvent: heavy chloroform): δ: 70.3, 73.6, 74.1, 76.7, 81.0, 86.0, 116.9, 117.0, 122.0, 127.4, 127.1, 128.0, 128.7, 133.0, 133.2, 135.7, 137.6, 142.3, 142.4 , 145.3, 150.8, 165.7, 165.8, 166.2

적외 흡수 스펙트럼(IR)(KBr) : 2925, 2855, 1760, 1652~1622, 809Infrared Absorption Spectrum (IR): 2925, 2855, 1760, 1652 ~ 1622, 809

(융점) 248℃(Melting point) 248 ℃

실시예 1에서 사용한 네마틱 액정 조성물에 식 (6)으로 나타내는 화합물을 2.0% 첨가해서 광학 현미경에 의해 구해지는 피치로부터 HTP를 산출한 결과, HTP=56이라는 높은 값을 나타냈다.As a result of adding 2.0% of the compound represented by Formula (6) to the nematic liquid crystal composition used in Example 1 and calculating HTP from the pitch calculated | required by an optical microscope, the high value of HTP = 56 was shown.

(실시예 4)(Example 4)

교반 장치, 냉각기 및 온도계를 구비한 반응 용기에, 실시예 1에서 합성한 식 (3)으로 나타내는 화합물 4g(10.3밀리몰), 6-아크릴로일옥시-2-나프토산 5.8g(24밀리몰), 디메틸아미노피리딘 200mg, 디클로로메탄 500㎖를 투입하고, 빙냉 배쓰에서 5℃ 이하로 반응 용기를 유지하고, 질소 가스의 분위기 하에서 디이소프로필카르보디이미드 3.6g(28밀리몰)을 천천히 적하했다. 적하 종료 후, 반응 용기를 실온으로 되돌려 5시간 반응시켰다. 반응액을 여과한 후, 여과액에 디클로로메탄 200㎖를 가하고, 10% 염산 수용액으로 세정하고, 포화 식염수로 더 세정하고, 유기층을 무수황산나트륨으로 건조시켰다. 용매를 유거한 후, 5배량(중량비)의 실리카겔 칼럼에 의해 정제를 행해 식 (7)로 나타내는 목적의 화합물 5.7g을 얻었다.4 g (10.3 mmol) of the compound represented by Formula (3) synthesized in Example 1, 5.8 g (24 mmol) of 6-acryloyloxy-2-naphthoic acid, in a reaction vessel equipped with a stirring device, a cooler and a thermometer, 200 mg of dimethylaminopyridine and 500 ml of dichloromethane were added, the reaction vessel was kept at 5 ° C or lower in an ice-cooled bath, and 3.6 g (28 mmol) of diisopropylcarbodiimide was slowly added dropwise under an atmosphere of nitrogen gas. After completion of the dropwise addition, the reaction vessel was returned to room temperature and allowed to react for 5 hours. After the reaction solution was filtered, 200 ml of dichloromethane was added to the filtrate, washed with 10% aqueous hydrochloric acid solution, further washed with saturated brine, and the organic layer was dried over anhydrous sodium sulfate. After distilling off the solvent, the product was purified by a silica gel column of 5 times (weight ratio) to obtain 5.7 g of the target compound represented by Formula (7).

Figure pat00035
Figure pat00035

(물성값)(Property value)

1H-NMR(용매 : 중클로로포름) : δ : 4.13~4.19(m, 4H), 4.77(m, 1H), 5.16(m, 1H), 5.50(m, 1H), 5.52(s, 1H), 6.04(d, 2H), 6.29(m, 2H), 6.65(d, 2H), 7.26~7.37(m, 8H), 8.10(d, 2H), 8.17(d, 2H), 8.24~8.27(m, 4H) 1 H-NMR (solvent: heavy chloroform): δ: 4.13 to 4.19 (m, 4H), 4.77 (m, 1H), 5.16 (m, 1H), 5.50 (m, 1H), 5.52 (s, 1H), 6.04 (d, 2H), 6.29 (m, 2H), 6.65 (d, 2H), 7.26-7.37 (m, 8H), 8.10 (d, 2H), 8.17 (d, 2H), 8.24-8.27 (m, 4H)

13C-NMR(용매 : 중클로로포름) : δ : 70.7, 73.5, 74.7, 78.5, 81.2, 86.1, 118.5, 122.1, 125.8, 126.5, 127.6, 128.0, 130.3, 130.9, 131.1, 133.1, 136.2, 150.2, 164.3, 165.5, 165.9 13 C-NMR (solvent: heavy chloroform): δ: 70.7, 73.5, 74.7, 78.5, 81.2, 86.1, 118.5, 122.1, 125.8, 126.5, 127.6, 128.0, 130.3, 130.9, 131.1, 133.1, 136.2, 150.2, 164.3 , 165.5, 165.9

적외 흡수 스펙트럼(IR)(KBr) : 2925, 2855, 1760, 1652~1622, 809Infrared Absorption Spectrum (IR): 2925, 2855, 1760, 1652 ~ 1622, 809

(융점) 179℃179 ℃ (melting point)

실시예 1과 마찬가지로 해서 HTP를 산출한 결과, HTP=34라는 높은 값을 나타냈다.As a result of HTP being calculated in the same manner as in Example 1, a high value of HTP = 34 was shown.

(실시예 5)(Example 5)

다음으로, 교반 장치, 냉각기 및 온도계를 구비한 반응 용기에, (R)-1,1'-2-비나프톨 15.7g(55밀리몰), 4-(4'-아크릴로일옥시)비페닐카르복시산 35.3g(130밀리몰) 디메틸아미노피리딘 1.8g, 디클로로메탄 500㎖를 투입하고 빙냉 배쓰에서 5℃ 이하로 반응 용기를 유지하고, 질소 가스의 분위기 하에서 디이소프로필카르보디이미드 19g(150밀리몰)을 천천히 적하했다. 적하 종료 후, 반응 용기를 실온으로 되돌려 5시간 반응시켰다. 반응액을 여과한 후, 여과액에 디클로로메탄 200㎖를 가하고, 10% 염산 수용액으로 세정하고, 포화 식염수로 더 세정하고, 유기층을 무수황산나트륨으로 건조시켰다. 용매를 유거한 후, 5배량(중량비)의 실리카겔 칼럼에 의해 정제를 행해 식 (8)로 나타내는 목적의 화합물(R체) 35g을 얻었다.Next, 15.7 g (55 mmol) of (R) -1,1'-2-binaftol and 4- (4'-acryloyloxy) biphenylcarboxylic acid were added to the reaction vessel provided with a stirring device, a cooler, and a thermometer. 1.8 g of 35.3 g (130 mmol) dimethylaminopyridine and 500 ml of dichloromethane were added thereto, and the reaction vessel was kept at 5 ° C or lower in an ice-cooled bath, and 19 g (150 mmol) of diisopropylcarbodiimide was slowly added under an atmosphere of nitrogen gas. Dropped. After completion of the dropwise addition, the reaction vessel was returned to room temperature and allowed to react for 5 hours. After the reaction solution was filtered, 200 ml of dichloromethane was added to the filtrate, washed with 10% aqueous hydrochloric acid solution, further washed with saturated brine, and the organic layer was dried over anhydrous sodium sulfate. After distilling a solvent off, it refine | purified by the silica gel column of 5 times (weight ratio), and obtained the target compound (R body) 35g shown by Formula (8).

Figure pat00036
Figure pat00036

(물성값)(Property value)

1H-NMR(용매:중클로로포름) : δ : 4.05~4.11(m, 4H), 4.67(m, 1H), 5.06(m, 1H), 5.42(m, 1H), 5.49(s, 1H), 6.04(d, 2H), 6.29(m, 2H), 6.65(d, 2H), 7.26~7.37(m, 8H), 8.10(d, 2H), 8.17(d, 2H), 8.24~8.27(m, 4H) 1 H-NMR (solvent: heavy chloroform): δ: 4.05 to 4.11 (m, 4H), 4.67 (m, 1H), 5.06 (m, 1H), 5.42 (m, 1H), 5.49 (s, 1H), 6.04 (d, 2H), 6.29 (m, 2H), 6.65 (d, 2H), 7.26-7.37 (m, 8H), 8.10 (d, 2H), 8.17 (d, 2H), 8.24-8.27 (m, 4H)

13C-NMR(용매 : 중클로로포름) : δ : 121.7, 121.9, 123.6, 125.7, 126.1, 126.8, 127.7, 128.0, 128.2, 129.6, 130.4, 131.5, 132.3, 133.3, 137.6, 144.9, 146.9, 150.6, 164.4, 164.5 13 C-NMR (solvent: heavy chloroform): δ: 121.7, 121.9, 123.6, 125.7, 126.1, 126.8, 127.7, 128.0, 128.2, 129.6, 130.4, 131.5, 132.3, 133.3, 137.6, 144.9, 146.9, 150.6, 164.4 , 164.5

적외 흡수 스펙트럼(IR)(KBr) : 1760, 1652~1622, 809Infrared Absorption Spectrum (IR): 1760, 1652-1622, 809

(융점) 107℃(Melting point) 107 ° C

실시예 1과 마찬가지로 해서 HTP를 산출한 결과, HTP=65라는 높은 값을 나타냈다.As a result of HTP being calculated in the same manner as in Example 1, a high value of HTP = 65 was shown.

(비교예 1)(Comparative Example 1)

교반 장치, 냉각기, 및 온도계를 구비한 반응 용기에 4-(4-하이드록시 페닐)벤조산 21.4g(100밀리몰), 요오드화칼륨 2.5g, 테트라부틸암모늄브로마이드 0.7g, 에탄올 400㎖를 투입해서 실온에서 교반했다. 수산화나트륨 12g의 25% 수용액을 천천히 적하했다. 적하 종료 후, 반응 용기를 50℃로 유지하고, 6-클로로프로판올 20g(150밀리몰)을 천천히 적하했다. 적하 종료 후, 반응 용기를 70℃로 더 가온해서 3시간 더 반응시켰다. 반응 종료 후, 10% 염산으로 중화해서 아세트산에틸로 추출을 행하고, 황산나트륨으로 건조 후, 용매를 농축해서 식 (9)로 나타내는 화합물을 22g 합성했다.21.4 g (100 mmol) of 4- (4-hydroxyphenyl) benzoic acid, 2.5 g of potassium iodide, 0.7 g of tetrabutylammonium bromide and 400 ml of ethanol were added to a reaction vessel equipped with a stirring device, a cooler, and a thermometer at room temperature. Stirred. A 25% aqueous solution of 12 g of sodium hydroxide was slowly added dropwise. After completion of the dropwise addition, the reaction vessel was maintained at 50 ° C, and 20 g (150 mmol) of 6-chloropropanol was slowly added dropwise. After completion of the dropwise addition, the reaction vessel was further warmed to 70 ° C and allowed to react for 3 hours. After the completion of the reaction, the mixture was neutralized with 10% hydrochloric acid, extracted with ethyl acetate, dried over sodium sulfate, and the solvent was concentrated to synthesize 22 g of the compound represented by the formula (9).

Figure pat00037
Figure pat00037

다음으로, 교반 장치, 냉각기 및 딘스타크를 구비한 반응 용기에, 상기에서 합성한 식 (9)로 나타내는 화합물 22g(71밀리몰), 아크릴산 10g(140밀리몰), p-톨루엔술폰산 1g, 톨루엔 100㎖를 투입했다. 반응 용기를 가열해서 톨루엔 환류시켜 그대로 4시간 반응시켰다. 반응 종료 후, 반응액을 포화 탄산수소나트륨으로 세정한 후, 10% 염산 수용액으로 중화, 포화 식염수로 더 세정하고, 유기층을 무수황산나트륨으로 건조시켰다. 용매를 유거해서 식 (10)으로 나타내는 화합물 19g을 얻었다.Next, 22 g (71 mmol) of the compound represented by Formula (9) synthesized above, 10 g (140 mmol) of acrylic acid, 1 g of p-toluenesulfonic acid, and 100 ml of toluene were added to a reaction vessel equipped with a stirring device, a cooler, and Dean Stark. Committed. The reaction vessel was heated to reflux with toluene and reacted as it was for 4 hours. After completion of the reaction, the reaction solution was washed with saturated sodium hydrogen carbonate, neutralized with 10% aqueous hydrochloric acid solution, further washed with saturated brine, and the organic layer was dried over anhydrous sodium sulfate. The solvent was distilled off and 19g of compounds represented by Formula (10) were obtained.

Figure pat00038
Figure pat00038

또한, 교반 장치, 냉각기 및 온도계를 구비한 반응 용기에, 상기에서 합성한 식 (10)으로 나타내는 화합물 19g(51밀리몰), 이소소르바이드 3.8g(27밀리몰), 디메틸아미노피리딘 0.9g, 디클로로메탄 200㎖를 투입하고, 빙냉 배쓰에서 5℃ 이하로 반응 용기를 유지하고, 질소 가스의 분위기 하에서 디이소프로필카르보디이미드9g(6.3밀리몰)을 천천히 적하했다. 적하 종료 후, 반응 용기를 실온으로 되돌려 5시간 반응시켰다. 반응액을 여과한 후, 여과액에 디클로로메탄 100㎖를 가하고, 10% 염산 수용액으로 세정하고, 포화 식염수로 더 세정하고, 유기층을 무수황산나트륨으로 건조시켰다. 용매를 유거한 후, 실리카겔 칼럼 및 재결정에 의해 정제를 행해 식 (11)로 나타내는 목적의 화합물 14g을 얻었다. 이 화합물의 융점은 150℃이상이며 측정할 수 없었다.In addition, 19 g (51 mmol) of the compound represented by Formula (10) synthesized above, 3.8 g (27 mmol) of isosorbide, 0.9 g of dimethylaminopyridine, 0.9 g of dichloromethane, were added to a reaction vessel equipped with a stirring device, a cooler, and a thermometer. 200 ml was put, the reaction container was hold | maintained at 5 degrees C or less in the ice-cooling bath, and 9 g (6.3 mmol) of diisopropyl carbodiimide was slowly dripped under the atmosphere of nitrogen gas. After completion of the dropwise addition, the reaction vessel was returned to room temperature and allowed to react for 5 hours. After the reaction solution was filtered, 100 mL of dichloromethane was added to the filtrate, washed with 10% aqueous hydrochloric acid solution, further washed with saturated brine, and the organic layer was dried over anhydrous sodium sulfate. After distilling off the solvent, purification was carried out by silica gel column and recrystallization to obtain 14 g of the target compound represented by the formula (11). Melting | fusing point of this compound was 150 degreeC or more and was not able to be measured.

Figure pat00039
Figure pat00039

(물성값)(Property value)

1H-NMR(용매 : 중클로로포름) : δ : 1.55~1.45(m, 8H), 1.71(m, 4H), 1.83(m, 4H), 2.66(m, 4H), 2.96(m, 4H), 3.93(m, 2H), 3.98(m, 2H), 4.03(s, 4H), 4.30(t, 4H), 4.50(t, 4H), 5.35(s, 2H), 5.65(dd, 2H), 5.85(d, 2H), 5.85(d, 2H), 6.15(q, 2H), 6.55(d, 2H), 7.10(d, 4H), 7.50(m, 4H), 8.12(d, 4H), 8.13(d, 4H) 1 H-NMR (solvent: heavy chloroform): δ: 1.55 to 1.45 (m, 8H), 1.71 (m, 4H), 1.83 (m, 4H), 2.66 (m, 4H), 2.96 (m, 4H), 3.93 (m, 2H), 3.98 (m, 2H), 4.03 (s, 4H), 4.30 (t, 4H), 4.50 (t, 4H), 5.35 (s, 2H), 5.65 (dd, 2H), 5.85 (d, 2H), 5.85 (d, 2H), 6.15 (q, 2H), 6.55 (d, 2H), 7.10 (d, 4H), 7.50 (m, 4H), 8.12 (d, 4H), 8.13 ( d, 4H)

적외 흡수 스펙트럼(IR)(KBr) : 2925, 2855, 1760, 1652~1622, 809Infrared Absorption Spectrum (IR): 2925, 2855, 1760, 1652 ~ 1622, 809

(융점) >150℃(Melting point)> 150 ℃

비교예 1 기재의 식 (11)로 표시되는 화합물은, 융점이 높아 다른 화합물과의 용해성에도 문제가 있었다. 실시예 1과 마찬가지의 액정 조성물로 HTP를 산출한 결과, HTP=33라는 높은 값을 나타냈지만, 용해성이 나쁘기 때문에 하기한 조성에 0.5%밖에 첨가할 수 없었다.The compound represented by Formula (11) described in Comparative Example 1 had a high melting point and also had problems with solubility with other compounds. When HTP was calculated by the same liquid crystal composition as in Example 1, the high value of HTP was 33, but since solubility was bad, only 0.5% could be added to the following composition.

(비교예 2)(Comparative Example 2)

교반 장치, 냉각기 및 온도계를 구비한 반응 용기에 p-하이드록시페닐신남산 19.6g(120밀리몰), 요오드화칼륨 2g, 테트라부틸암모늄브로마이드 0.5g, 에탄올 400㎖를 투입해 실온에서 교반했다. 수산화나트륨 12g의 25% 수용액을 천천히 적하했다. 적하 종료 후, 반응 용기를 50℃로 유지하고, 벤질브로마이드 25g(144밀리몰)을 천천히 적하했다. 적하 종료 후, 반응 용기를 70℃로 더 가온해서 3시간 더 반응시켰다. 반응 종료 후, 10% 염산으로 중화해서 아세트산에틸로 추출을 행하고, 황산나트륨으로 건조 후, 용매를 농축해서 식 (12)로 나타내는 화합물을 21g 합성했다.19.6 g (120 mmol) of p-hydroxyphenyl cinnamic acid, 2 g of potassium iodide, 0.5 g of tetrabutylammonium bromide, and 400 ml of ethanol were added to a reaction vessel provided with a stirring device, a cooler, and a thermometer, and stirred at room temperature. A 25% aqueous solution of 12 g of sodium hydroxide was slowly added dropwise. After completion of the dropwise addition, the reaction vessel was maintained at 50 ° C, and 25 g (144 mmol) of benzyl bromide was slowly added dropwise. After completion of the dropwise addition, the reaction vessel was further warmed to 70 ° C and allowed to react for 3 hours. After the completion of the reaction, the mixture was neutralized with 10% hydrochloric acid, extracted with ethyl acetate, dried over sodium sulfate, and the solvent was concentrated to synthesize 21 g of the compound represented by the formula (12).

Figure pat00040
Figure pat00040

다음으로, 교반 장치, 냉각기 및 온도계를 구비한 반응 용기에, 상기에서 합성한 식 (12)로 나타내는 화합물 21g(82밀리몰), 이소소르바이드 6g(41밀리몰), 디메틸아미노피리딘 1g, 디클로로메탄 500㎖를 투입하고, 빙냉 배쓰에서 5℃ 이하로 반응 용기를 유지하고, 질소 가스의 분위기 하에서 디이소프로필카르보디이미드 12.4g(100밀리몰)을 천천히 적하했다. 적하 종료 후, 반응 용기를 실온으로 되돌려 5시간 반응시켰다. 반응액을 여과한 후, 여과액에 디클로로메탄 200㎖를 가하고, 10% 염산 수용액으로 세정하고, 포화 식염수로 더 세정하고, 유기층을 무수황산나트륨으로 건조시켰다. 용매를 유거한 후, 5배량(중량비)의 실리카겔 칼럼에 의해 정제를 행해 19g을 얻었다.Next, 21 g (82 mmol) of the compound represented by Formula (12) synthesized above, isosorbide 6 g (41 mmol), 1 g of dimethylaminopyridine, 1 g of dichloromethane, and the like in a reaction vessel equipped with a stirring device, a cooler, and a thermometer. ML was added, the reaction container was hold | maintained at 5 degrees C or less in the ice-cooling bath, and 12.4 g (100 mmol) of diisopropyl carbodiimide was slowly dripped under the atmosphere of nitrogen gas. After completion of the dropwise addition, the reaction vessel was returned to room temperature and allowed to react for 5 hours. After the reaction solution was filtered, 200 ml of dichloromethane was added to the filtrate, washed with 10% aqueous hydrochloric acid solution, further washed with saturated brine, and the organic layer was dried over anhydrous sodium sulfate. After distilling off the solvent, the product was purified by a silica gel column of 5 times (weight ratio) to obtain 19 g.

다음으로, 교반 장치를 구비한 오토클레이브 용기에, 상기에서 합성한 중간체 19g, 팔라듐카본 1g, 에탄올 150㎖, 테트라하이드로푸란 100㎖를 투입하고, 1기압의 수소로 환원 반응(반응 온도 50℃, 3시간)을 행했다. 반응액을 여과한 후, 반응 용매를 유거해서 식 (13)으로 나타내는 화합물 11.5g을 얻었다.Next, 19 g of the intermediate synthesized above, 1 g of palladium carbon, 150 ml of ethanol, and 100 ml of tetrahydrofuran were added to an autoclave vessel equipped with a stirring device, and the reaction was reduced with 1 atmosphere of hydrogen (reaction temperature 50 ° C, 3 hours). After filtering the reaction liquid, the reaction solvent was distilled off and the compound 11.5g represented by Formula (13) was obtained.

Figure pat00041
Figure pat00041

다음으로 교반 장치, 냉각기 및 온도계를 구비한 반응 용기에, 상기에서 합성한 식 (13)으로 나타내는 화합물 11.5g(26밀리몰), 4-(4-아크릴로일옥시헥실옥시)벤조산 15.2g(52밀리몰), 디메틸아미노피리딘 0.8g, 디클로로메탄 300㎖를 투입하고, 빙냉 배쓰에서 5℃ 이하로 반응 용기를 유지하고, 질소 가스의 분위기 하에서 디이소프로필카르보디이미드 7.8g(64밀리몰)을 천천히 적하했다. 적하 종료 후, 반응 용기를 실온으로 되돌려 5시간 반응시켰다. 반응액을 여과한 후, 여과액에 디클로로메탄 100㎖를 가하고, 10% 염산 수용액으로 세정하고, 포화 식염수로 더 세정하고, 유기층을 무수황산나트륨으로 건조시켰다. 용매를 유거한 후, 실리카겔 칼럼 및 재결정에 의해 정제를 행해 식 (14)로 나타내는 목적의 화합물 18g을 얻었다.Next, 11.5 g (26 mmol) of the compound represented by Formula (13) synthesized above, and 15.2 g of 4- (4-acryloyloxyhexyloxy) benzoic acid in a reaction vessel equipped with a stirring device, a cooler, and a thermometer were prepared. 52 mmol), 0.8 g of dimethylaminopyridine and 300 ml of dichloromethane were added thereto, and the reaction vessel was kept at 5 ° C or lower in an ice-cooled bath, and 7.8 g (64 mmol) of diisopropylcarbodiimide was slowly added under an atmosphere of nitrogen gas. Dropped. After completion of the dropwise addition, the reaction vessel was returned to room temperature and allowed to react for 5 hours. After the reaction solution was filtered, 100 mL of dichloromethane was added to the filtrate, washed with 10% aqueous hydrochloric acid solution, further washed with saturated brine, and the organic layer was dried over anhydrous sodium sulfate. After distilling off the solvent, purification was performed by a silica gel column and recrystallization to obtain 18 g of the target compound represented by the formula (14).

Figure pat00042
Figure pat00042

(물성값)(Property value)

1H-NMR(용매 : 중클로로포름) : δ : 1.55~1.45(m, 8H), 1.71(m, 4H), 1.83(m, 4H), 2.66(m, 4H), 2.96(m, 4H), 3.76(m, 2H), 3.90(s, 4H), 4.03(t, 4H), 4.17(t, 4H), 4.29(t, 1H), 4.76(t, 1H), 5.18(d, 2H), 5.78(d, 2H), 6.15(q, 2H), 6.37(d, 2H), 6.96(d, 4H) 7.23(d, 4H), 7.25(m, 4H), 8.12(d, 4H) 1 H-NMR (solvent: heavy chloroform): δ: 1.55 to 1.45 (m, 8H), 1.71 (m, 4H), 1.83 (m, 4H), 2.66 (m, 4H), 2.96 (m, 4H), 3.76 (m, 2H), 3.90 (s, 4H), 4.03 (t, 4H), 4.17 (t, 4H), 4.29 (t, 1H), 4.76 (t, 1H), 5.18 (d, 2H), 5.78 (d, 2H), 6.15 (q, 2H), 6.37 (d, 2H), 6.96 (d, 4H) 7.23 (d, 4H), 7.25 (m, 4H), 8.12 (d, 4H)

13C-NMR(용매 : 중클로로포름) : δ : 25.6, 28.4, 28.8, 30.1, 30.2, 35.3, 35.5, 64.3, 67.9, 73.0, 73.8, 80.6, 85.7, 114.0, 121.3, 121.5, 128.3, 129.0, 130.2, 131.9, 137.1, 137.4, 149.2, 163.0, 164.5, 165.9, 171.3, 171.6 13 C-NMR (solvent: heavy chloroform): δ: 25.6, 28.4, 28.8, 30.1, 30.2, 35.3, 35.5, 64.3, 67.9, 73.0, 73.8, 80.6, 85.7, 114.0, 121.3, 121.5, 128.3, 129.0, 130.2 , 131.9, 137.1, 137.4, 149.2, 163.0, 164.5, 165.9, 171.3, 171.6

적외 흡수 스펙트럼(IR)(KBr) : 2925, 2855, 1760, 1652~1622, 809Infrared Absorption Spectrum (IR): 2925, 2855, 1760, 1652 ~ 1622, 809

(융점) 79℃(Melting point) 79 ℃

식 (14)로 표시되는 화합물은, 융점이 79℃로 낮아, 다른 액정성 화합물과의 용해성이 우수하지만, 실시예 1과 마찬가지로 해서 HTP를 산출한 결과, HTP=12라는 낮은 값이었다.The compound represented by the formula (14) had a low melting point of 79 ° C. and excellent solubility with other liquid crystal compounds, but the HTP was calculated in the same manner as in Example 1, and the low value was HTP = 12.

(실시예 6) 중합성 액정 조성물의 조제Example 6 Preparation of Polymerizable Liquid Crystal Composition

이하에서 나타내는 조성의 중합성 액정 조성물(조성물 1)을 조제했다.The polymeric liquid crystal composition (composition 1) of the composition shown below was prepared.

Figure pat00043
Figure pat00043

중합성 액정 조성물은, 양호한 상용 안정성을 갖고, 콜레스테릭 액정상을 나타냈다. 이 조성물에 광중합 개시제 벤질디메틸케탈(상품명 이르가큐어 651 치바 스페셜리티 케미컬사제)을 조성물 1의 100g에 대하여 1g 첨가해서 중합성 액정 조성물(조성물 2)을 조제했다. 이 조성물 2를, 진공 주입법에 의해, 세로 5㎝, 가로 5㎝, 갭 5㎛의 폴리이미드 부착 셀에 주입했다. 이것에 고압 수은 램프를 사용해서 4㎽/㎠의 자외선을 120초간 조사한 바, 조성물 2가 균일한 배향 상태를 유지한 채로 중합해 광학 이방체가 얻어졌다. 이 광학 이방체는 양호한 원편광 특성을 갖고 있었다.The polymerizable liquid crystal composition had good commercial stability and exhibited a cholesteric liquid crystal phase. 1 g of a photoinitiator benzyl dimethyl ketal (brand name Irgacure 651 Chiba Specialty Chemical Co., Ltd.) was added to this composition with respect to 100 g of composition 1, and the polymeric liquid crystal composition (composition 2) was prepared. This composition 2 was injected into the cell with a polyimide of 5 cm in length, 5 cm in width, and 5 micrometers of gaps by the vacuum injection method. When this was irradiated with ultraviolet light of 4 mA / cm <2> for 120 second using the high pressure mercury lamp, the composition 2 superposed | polymerized while maintaining a uniform orientation state, and the optically anisotropic body was obtained. This optically anisotropic body had favorable circularly polarized light characteristic.

(비교예 3) 중합성 액정 조성물의 조제Comparative Example 3 Preparation of Polymerizable Liquid Crystal Composition

이하에 나타내는 조성의 중합성 액정 조성물(조성물 5)을 조제했다.The polymeric liquid crystal composition (composition 5) of the composition shown below was prepared.

Figure pat00044
Figure pat00044

중합성 액정 조성물은, 콜레스테릭 액정상을 나타냈지만, 배향성이 나빠 불균일했다. 이 조성물에 광중합 개시제 벤질디메틸케탈(상품명 이르가큐어 651 치바 스페셜리티 케미컬사제)을 조성물 5의 100g에 대하여 1g 첨가해서 중합성 액정 조성물(조성물 6)을 조제했다. 이 조성물 6을, 진공 주입법에 의해, 세로 5㎝, 가로 5㎝, 갭 5㎛의 폴리이미드 부착 셀에 주입했다. 이것에 고압 수은 램프를 사용해서 4㎽/㎠의 자외선을 120초간 조사한 바, 이 광학 이방체는 원편광 특성을 갖고 있었지만, 백탁되어 있고 불균일한 광학 이방체였다.Although the polymeric liquid crystal composition showed the cholesteric liquid crystal phase, the orientation was bad and it was nonuniform. 1 g of a photoinitiator benzyl dimethyl ketal (brand name Irgacure 651 Chiba Specialty Chemical Co., Ltd.) was added to this composition with respect to 100 g of composition 5, and the polymeric liquid crystal composition (composition 6) was prepared. This composition 6 was injected into the cell with a polyimide of 5 cm in length, 5 cm in width, and 5 micrometers of gaps by the vacuum injection method. When this was irradiated with ultraviolet rays of 4 kW / cm 2 for 120 seconds using a high-pressure mercury lamp, the optically anisotropic body had a circularly polarized light characteristic, but was a cloudy and uneven optically anisotropic body.

Claims (9)

일반식 (I)
Figure pat00045

(단, R1 및 R2는 서로 독립하여 이하의 식 (R-1) 내지 식 (R-15) 중 어느 하나를 나타내고,
Figure pat00046

A1, A2, A3 및 A4는 서로 독립하여 1,4-페닐렌기, 나프탈렌-2,6-디일기, 1,4-시클로헥실렌기 또는 피리딘-2,5-디일기를 나타내고, A1, A2, A3 및 A4에 포함되는 수소 원자는 서로 독립하여 알킬기, 할로겐화 알킬기, 알콕시기, 할로겐, 시아노기 또는 니트로기에 의해 치환되어 있어도 되고, B1 및 B2는 서로 독립하여, -O-, -S-, -OCH2-, -CH2O-, -CO-, -COO-, -OCO-, -OCOO-, -CO-NR11-, -NR11-CO-, -SCH2-, -CH2S-, -CH=CH-COO-, -OCO-CH=CH-, -COO-CH=CH-, -CH=CH-OCO-, -CH2CH2-COO-, -COO-CH2CH2-, -CH2CH2-OCO-, -OCO-CH2CH2-, -C≡C- 또는 단결합을 나타내고(단, R11은 수소 원자 또는 탄소수 1~4의 알킬기를 나타낸다), Z1은, -COO-, -CH=CH-COO-, -CH2CH2-COO-, -CH2O- 또는 -CF2O-를 나타내고, Z2는, -OCO-, -OCO-CH=CH-, -OCO-CH2CH2-, -OCH2- 또는 -OCF2-를 나타내고, Z는 이하의 일반식 (Z-1) 내지 (Z-3)으로 표시되는 2가의 치환기 중 어느 하나를 나타내고,
Figure pat00047

(식 중, 각 치환기는 점선으로 표시되는 결합의 한쪽에서 Z1에 다른 쪽에서 Z2와 결합하는 것을 나타내고 있고, Y1, Y2, Y3, Y4, Y5 및 Y6은, 각각 독립하여 탄소수 1~10의 알킬기, 탄소수 1~10의 알콕시기 및 수소 원자를 나타내고, 식 중의 일반식 (Z-1) 내지 (Z-3)으로 표시되는 2가의 치환기는 단일한 입체 구조를 나타낸다) m 및 n은 서로 독립하여, 0, 1 또는 2를 나타내지만, A1, A2, B1 또는/및 B2가 복수 존재할 경우 그들은 서로 독립하여 동일해도 상이해도 된다)로 표시되는 중합성 키랄 화합물.
The compound of formula (I)
Figure pat00045

(However, R 1 and R 2 independently of each other represent any one of the following formula (R-1) to formula (R-15),
Figure pat00046

A 1 , A 2 , A 3 and A 4 independently of each other represent a 1,4-phenylene group, a naphthalene-2,6-diyl group, a 1,4-cyclohexylene group or a pyridine-2,5-diyl group And hydrogen atoms contained in A 1 , A 2 , A 3, and A 4 may be each independently substituted with an alkyl group, a halogenated alkyl group, an alkoxy group, a halogen, a cyano group, or a nitro group, and B 1 and B 2 may be independent from each other. -O-, -S-, -OCH 2- , -CH 2 O-, -CO-, -COO-, -OCO-, -OCOO-, -CO-NR 11- , -NR 11 -CO- , -SCH 2- , -CH 2 S-, -CH = CH-COO-, -OCO-CH = CH-, -COO-CH = CH-, -CH = CH-OCO-, -CH 2 CH 2- COO-, -COO-CH 2 CH 2- , -CH 2 CH 2 -OCO-, -OCO-CH 2 CH 2- , -C≡C- or a single bond (wherein R 11 represents a hydrogen atom or carbon number) 1-4 represents an alkyl group), Z 1 is, -COO-, -CH = CH-COO- , -CH 2 CH 2 -COO-, -CH 2 O- or -CF represents a 2 O-, Z 2 Represents -OCO-, -OCO-CH = CH-, -OCO-CH 2 CH 2- , -OCH 2 -or -OCF 2- , Z represents the following general formulas (Z-1) to (Z- 3) as mark It represents any one of divalent substituents,
Figure pat00047

(In the formulas, each substituent indicates bonding to Z 1 on one side of the bond represented by a dotted line and Z 2 on the other side, and Y 1 , Y 2 , Y 3 , Y 4 , Y 5, and Y 6 are each independently. To an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, and a hydrogen atom, and the divalent substituent represented by general formulas (Z-1) to (Z-3) in the formula represents a single three-dimensional structure) m and n, independently of each other, represent 0, 1 or 2, but when a plurality of A 1 , A 2 , B 1 or / and B 2 are present, they may be the same as or different from each other independently; compound.
제1항에 있어서,
A1, A2, A3 및 A4가 서로 독립하여, 1,4-페닐렌기, 나프탈렌-2,6-디일기를 나타내는(A2 및 A3은 서로 독립하여 알킬기, 할로겐화 알킬기, 알콕시기, 할로겐, 시아노기 또는 니트로기에 의해 치환되어 있어도 된다) 중합성 키랄 화합물.
The method of claim 1,
A 1 , A 2 , A 3 and A 4 independently of each other represent a 1,4-phenylene group and a naphthalene-2,6-diyl group (A 2 and A 3 independently of each other are an alkyl group, a halogenated alkyl group, an alkoxy group) , Halogen, cyano group or nitro group may be substituted).
제1항에 있어서,
B1 및 B2가 서로 독립하여 -OCH2-, -CH2O-, -CO-, -COO-, -OCO-, -CH=CH-COO-, -OCO-CH=CH-, -CH2CH2-COO-, -OOC-CH2CH2-, -CH2CH2-OCO-, -OCO-CH2CH2-, -C≡C- 또는 단결합을 나타내는 중합성 키랄 화합물.
The method of claim 1,
B 1 and B 2 independently of one another are -OCH 2- , -CH 2 O-, -CO-, -COO-, -OCO-, -CH = CH-COO-, -OCO-CH = CH-, -CH 2 CH 2 -COO-, -OOC-CH 2 CH 2- , -CH 2 CH 2 -OCO-, -OCO-CH 2 CH 2- , -C≡C- or a polymerizable chiral compound exhibiting a single bond.
제1항에 있어서,
Z1이 -COO- 또는 -CH=CH-COO-을 나타내고, Z2가 -OCO- 또는 -OCO-CH=CH-을 나태내는 중합성 키랄 화합물.
The method of claim 1,
A polymeric chiral compound in which Z 1 represents -COO- or -CH = CH-COO- and Z 2 represents -OCO- or -OCO-CH = CH-.
제1항에 있어서,
Z가 일반식 (Z-1) 또는 (Z-3)으로 표시되는 2가의 치환기를 나타내는 중합성 키랄 화합물.
The method of claim 1,
Polymeric chiral compound in which Z represents a bivalent substituent represented by general formula (Z-1) or (Z-3).
제1항에 있어서,
m 및 n이 서로 독립하여 0, 1을 나타내는 중합성 키랄 화합물.
The method of claim 1,
A polymeric chiral compound in which m and n represent 0 and 1 independently of each other.
제1항에 있어서,
Z가 일반식 (Z-1)로 표시되는 2가의 치환기를 나타내는 중합성 키랄 화합물.
The method of claim 1,
A polymeric chiral compound in which Z represents a bivalent substituent represented by general formula (Z-1).
제1항 내지 제7항 중 어느 한 항에 기재된 중합성 키랄 화합물을 함유하는 중합성 조성물.The polymerizable composition containing the polymerizable chiral compound according to any one of claims 1 to 7. 제8항에 기재된 중합성 조성물을 사용한 광학 이방체.The optically anisotropic body using the polymeric composition of Claim 8.
KR1020120116633A 2011-10-21 2012-10-19 Polymerizable chiral compound KR20130044178A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPJP-P-2011-231702 2011-10-21
JP2011231702A JP5962945B2 (en) 2011-10-21 2011-10-21 Polymerizable chiral compound

Publications (1)

Publication Number Publication Date
KR20130044178A true KR20130044178A (en) 2013-05-02

Family

ID=48101964

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120116633A KR20130044178A (en) 2011-10-21 2012-10-19 Polymerizable chiral compound

Country Status (3)

Country Link
JP (1) JP5962945B2 (en)
KR (1) KR20130044178A (en)
CN (1) CN103059036B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103351705A (en) * 2013-06-09 2013-10-16 北京印刷学院 Preparation method of liquid crystal anti-counterfeit pigment
CN103343014B (en) * 2013-06-21 2014-12-03 惠州市华阳光学技术有限公司 Liquid crystal composition
CN103409145B (en) * 2013-07-31 2015-09-02 江苏和成显示科技股份有限公司 Polymerizable liquid crystal compound and application thereof
US9441164B2 (en) * 2013-07-31 2016-09-13 Semiconductor Energy Laboratory Co., Ltd. Isosorbide derivative, liquid crystal composition, liquid crystal element, and liquid crystal display device
US10294426B2 (en) * 2014-07-28 2019-05-21 Merck Patent Gmbh Liquid crystalline media having homeotropic alignment
JP6858251B2 (en) 2017-04-20 2021-04-14 富士フイルム株式会社 Compounds, liquid crystal compositions, cured products, optically anisotropic substances, and reflective films
JP7082127B2 (en) * 2017-06-29 2022-06-07 Dic株式会社 A polymerizable liquid crystal composition, an optical film using the same, and a method for producing the same.
EP3770657A4 (en) 2018-03-23 2021-06-02 FUJIFILM Corporation Cholesteric liquid crystal layer, laminated body, optically anisotropic body, reflective film, production method for cholesteric liquid crystal layer; forgery prevention medium, and determination method
EP3770656A4 (en) 2018-03-23 2021-06-02 FUJIFILM Corporation Cholesteric liquid crystal layer production method, cholesteric liquid crystal layer, liquid crystal composition, cured product, optically anisotropic body, and reflective layer
KR20210058569A (en) 2019-11-14 2021-05-24 삼성전자주식회사 High thermal conductive epoxy compound, and composition, material for semiconductor package, molded propuct, electric and electronic device and semiconductor package including the same
KR20210058453A (en) 2019-11-14 2021-05-24 삼성전자주식회사 High thermal conductive epoxy compound, and composition, material for semiconductor package, molded propuct, electric and electronic device and semiconductor package including the same
KR20220124229A (en) * 2020-02-18 2022-09-13 후지필름 가부시키가이샤 compound, liquid crystal composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342280A1 (en) * 1993-12-11 1995-06-14 Basf Ag Polymerizable chiral compounds and their use
DE19619460A1 (en) * 1996-05-14 1997-11-20 Consortium Elektrochem Ind Liquid crystalline material with definite birefringence for visible light and selective ultra-violet properties
DE19640619A1 (en) * 1996-10-01 1998-04-02 Basf Ag Flat structures with cholesteric, liquid crystalline structure
DE19843724A1 (en) * 1997-10-08 1999-04-15 Basf Ag Chiral compound used as polymerizable, high-twisting-power dopant for the production of cholesteric networks
US20020013482A1 (en) * 2000-07-13 2002-01-31 Consortium Fur Elektrochemische Industrie Gmbh Process for the preparation of dianhydrohexitol bis(4-acryloyloxy)acylates
DE10325610A1 (en) * 2003-06-05 2004-12-30 Consortium für elektrochemische Industrie GmbH Polymer film with a helical molecular structure
JP4599948B2 (en) * 2003-09-18 2010-12-15 チッソ株式会社 α-Fluoroacrylate compound, composition and polymer thereof
JP4802479B2 (en) * 2004-02-18 2011-10-26 Jnc株式会社 Polymerizable binaphthalene derivative
JP5076414B2 (en) * 2005-11-29 2012-11-21 Jnc株式会社 Polymerizable optically active compound and composition thereof
JP4961795B2 (en) * 2006-03-30 2012-06-27 Dic株式会社 Polymerizable chiral compound
JP5103774B2 (en) * 2006-03-30 2012-12-19 Dic株式会社 Polymerizable chiral compound
JP5288156B2 (en) * 2007-09-28 2013-09-11 Dic株式会社 Polymerizable chiral compound
TWI494316B (en) * 2008-09-11 2015-08-01 Dainippon Ink & Chemicals Polymerizable chiral compounds
JP5493629B2 (en) * 2008-11-07 2014-05-14 Jnc株式会社 Polymerizable liquid crystal composition
ES2498725T3 (en) * 2009-12-08 2014-09-25 Sicpa Holding Sa Modified labeling based on polymers of chiral liquid crystals
JP2011225520A (en) * 2010-04-02 2011-11-10 Jnc Corp Photoactive compound having polymerizable group and polymer thereof

Also Published As

Publication number Publication date
JP2013087109A (en) 2013-05-13
JP5962945B2 (en) 2016-08-03
CN103059036B (en) 2017-06-06
CN103059036A (en) 2013-04-24

Similar Documents

Publication Publication Date Title
JP5962945B2 (en) Polymerizable chiral compound
JP5103774B2 (en) Polymerizable chiral compound
JP4961795B2 (en) Polymerizable chiral compound
JP5168976B2 (en) Biphenyl and terphenyl compounds and polymerizable liquid crystal compositions containing the compounds
JP5103981B2 (en) Polymerizable compound having 5, 6 and 7 rings, and polymerizable liquid crystal composition containing the compound
KR101523330B1 (en) Polymerizable chiral compound
JP6031781B2 (en) Polymerizable compound and liquid crystal composition using the same
JP5125171B2 (en) Polymerizable compound
KR20170086047A (en) Polymerizable compound, composition, polymer, optically anisotropic body, liquid crystal display device and organic el element
JP5549174B2 (en) Polymerizable naphthalene compound
JP5288156B2 (en) Polymerizable chiral compound
JP6308415B2 (en) Polymerizable compound and liquid crystal composition using the same
JP2010189615A (en) Polymerizable biphenyl compound
JP2011093812A (en) Polymerizable compound
JP2002308831A (en) Polymerizable liquid crystal compound, polymerizable liquid crystal composition containing the compound and its polymer
KR101563574B1 (en) Polymerizable biphenyl compound
KR101648041B1 (en) Polymerizable compound
JP5375006B2 (en) Polymerizable liquid crystal compound
JP5545518B2 (en) Polymerizable biphenyl compound
JP5493416B2 (en) Polymerizable biphenyl compound
JP5787466B2 (en) Polyfunctional polymerizable compound
KR101649178B1 (en) Polymerizable naphthalene compound
JP2008239568A (en) Piperazine compound
JP2016169218A (en) Polymerizable compound and liquid crystal composition using the same

Legal Events

Date Code Title Description
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment